# EDGAR Filing Document

**Accession Number:** 0001314727
**File Stem:** 0001314727-26-000061
**Filing Date:** 2026-5
**Character Count:** 137055
**Document Hash:** 8de1b7c23e3c2e975eaf300c993bb734
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001314727-26-000061.hdr.sgml**: 20260505

**ACCESSION NUMBER**: 0001314727-26-000061

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 70

**CONFORMED PERIOD OF REPORT**: 20260328

**FILED AS OF DATE**: 20260505

**DATE AS OF CHANGE**: 20260504

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Sonos Inc
- **CENTRAL INDEX KEY:** 0001314727
- **STANDARD INDUSTRIAL CLASSIFICATION:** HOUSEHOLD AUDIO & VIDEO EQUIPMENT [3651]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 030479476
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1003

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38603
- **FILM NUMBER:** 26939461

**BUSINESS ADDRESS:**
- **STREET 1:** 301 COROMAR DRIVE
- **CITY:** SANTA BARBARA
- **STATE:** CA
- **ZIP:** 93117
- **BUSINESS PHONE:** 805-965-3001

**MAIL ADDRESS:**
- **STREET 1:** 301 COROMAR DRIVE
- **CITY:** SANTA BARBARA
- **STATE:** CA
- **ZIP:** 93117

?xml version='1.0' encoding='ASCII'? sono-20260328

**<u>[Table of contents](#i92d71685303e4745bebf668b98f078d9_7)</u>**

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**_________________________________________________________**

**FORM 10-Q** 

⌧ **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**<br>

**For the quarterly period ended March 28, 2026**

**or** 

□ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**<br>

**For the transition period from&nbsp;&nbsp;&nbsp;&nbsp; to**

**Commission File Number: 001-38603** 

**_________________________________________________________**

**SONOS, INC.** 

**(Exact name of registrant as specified in its charter)**

**_________________________________________________________**

---

| | | | |
|:---|:---|:---|:---|
| **Delaware** | | **03-0479476** | |
| (State or other jurisdiction<br>of incorporation or organization) | | (I.R.S. Employer Identification No.) | |
| **301 Coromar Drive** | **Santa Barbara** | **CA** | **93117** |
| (Address of Principal Executive Offices) | | | (Zip Code) |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(805) 965-3001

Registrant's telephone number, including area code

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Common Stock, $0.001 par value | SONO | The Nasdaq Stock Market LLC |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ⌧ No □

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ⌧ No □

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company", and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ⌧ | Accelerated filer | □ |
| Non-accelerated filer | □ | Smaller reporting company | □ |
| | | Emerging growth company | □ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. □

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes □ No ⌧

As of April 17, 2026, the registrant had 119,128,671 shares of common stock outstanding.

------

**<u>[Table of contents](#i92d71685303e4745bebf668b98f078d9_7)</u>**

**TABLE OF CONTENTS**

---

| | | |
|:---|:---|:---|
| | | **Page** |
| **<u>[PART I. FINANCIAL INFORMATION](#i92d71685303e4745bebf668b98f078d9_10)</u>** | **<u>[PART I. FINANCIAL INFORMATION](#i92d71685303e4745bebf668b98f078d9_10)</u>** | |
| **<u>[Item 1.](#i92d71685303e4745bebf668b98f078d9_13)</u>** | **<u>[Financial statements (unaudited)](#i92d71685303e4745bebf668b98f078d9_13)</u>** | |
|  | <u>[Condensed consolidated balance sheets](#i92d71685303e4745bebf668b98f078d9_16)</u> | <u>[3](#i92d71685303e4745bebf668b98f078d9_16)</u> |
|  | <u>[Condensed consolidated statements of operations and comprehensive income (loss)](#i92d71685303e4745bebf668b98f078d9_19)</u>  | <u>[4](#i92d71685303e4745bebf668b98f078d9_19)</u> |
|  | <u>[Condensed consolidated statements of stockholders' equity](#i92d71685303e4745bebf668b98f078d9_22)</u> | <u>[5](#i92d71685303e4745bebf668b98f078d9_22)</u> |
|  | <u>[Condensed consolidated statements of cash flows](#i92d71685303e4745bebf668b98f078d9_25)</u> | <u>[6](#i92d71685303e4745bebf668b98f078d9_25)</u> |
|  | <u>[Notes to condensed consolidated financial statements](#i92d71685303e4745bebf668b98f078d9_28)</u> | <u>[7](#i92d71685303e4745bebf668b98f078d9_28)</u> |
| **<u>[Item 2.](#i92d71685303e4745bebf668b98f078d9_73)</u>** | <u>[Management's discussion and analysis of financial condition and results of operations](#i92d71685303e4745bebf668b98f078d9_73)</u> | <u>[19](#i92d71685303e4745bebf668b98f078d9_73)</u> |
| **<u>[Item 3.](#i92d71685303e4745bebf668b98f078d9_109)</u>** | <u>[Quantitative and qualitative disclosures about market risk](#i92d71685303e4745bebf668b98f078d9_109)</u> | <u>[28](#i92d71685303e4745bebf668b98f078d9_109)</u> |
| **<u>[Item 4.](#i92d71685303e4745bebf668b98f078d9_112)</u>** | <u>[Controls and procedures](#i92d71685303e4745bebf668b98f078d9_112)</u> | <u>[29](#i92d71685303e4745bebf668b98f078d9_112)</u> |
| **<u>[PART II. OTHER INFORMATION](#i92d71685303e4745bebf668b98f078d9_115)</u>** | **<u>[PART II. OTHER INFORMATION](#i92d71685303e4745bebf668b98f078d9_115)</u>** |  |
| **<u>[Item 1.](#i92d71685303e4745bebf668b98f078d9_118)</u>** | <u>[Legal proceedings](#i92d71685303e4745bebf668b98f078d9_118)</u> | <u>[30](#i92d71685303e4745bebf668b98f078d9_118)</u> |
| **<u>[Item 1A.](#i92d71685303e4745bebf668b98f078d9_121)</u>** | <u>[Risk factors](#i92d71685303e4745bebf668b98f078d9_121)</u> | <u>[30](#i92d71685303e4745bebf668b98f078d9_121)</u> |
| **<u>[Item 2.](#i92d71685303e4745bebf668b98f078d9_124)</u>** | <u>[Unregistered sales of equity securities and use of proceeds](#i92d71685303e4745bebf668b98f078d9_124)</u> | <u>[30](#i92d71685303e4745bebf668b98f078d9_124)</u> |
| **<u>[Item 3.](#i92d71685303e4745bebf668b98f078d9_127)</u>** | <u>[Defaults upon senior securities](#i92d71685303e4745bebf668b98f078d9_127)</u> | <u>[31](#i92d71685303e4745bebf668b98f078d9_127)</u> |
| **<u>[Item 4.](#i92d71685303e4745bebf668b98f078d9_130)</u>** | <u>[Mine safety disclosures](#i92d71685303e4745bebf668b98f078d9_130)</u> | <u>[31](#i92d71685303e4745bebf668b98f078d9_130)</u> |
| **<u>[Item 5.](#i92d71685303e4745bebf668b98f078d9_133)</u>** | <u>[Other information](#i92d71685303e4745bebf668b98f078d9_133)</u> | <u>[31](#i92d71685303e4745bebf668b98f078d9_133)</u> |
| **<u>[Item 6.](#i92d71685303e4745bebf668b98f078d9_139)</u>** | <u>[Exhibit index](#i92d71685303e4745bebf668b98f078d9_139)</u> | <u>[32](#i92d71685303e4745bebf668b98f078d9_139)</u> |
| **<u>[SIGNATURES](#i92d71685303e4745bebf668b98f078d9_142)</u>** | **<u>[SIGNATURES](#i92d71685303e4745bebf668b98f078d9_142)</u>** | <u>[33](#i92d71685303e4745bebf668b98f078d9_142)</u> |

---

------

**<u>[Table of contents](#i92d71685303e4745bebf668b98f078d9_7)</u>**

**PART I. FINANCIAL INFORMATION**

**Item 1.&nbsp;&nbsp;&nbsp;&nbsp; Financial statements** 

**SONOS, INC.**

**CONDENSED CONSOLIDATED BALANCE SHEETS**

*(unaudited, in thousands, except par values)*

---

| | | |
|:---|:---|:---|
| | **As of** | **As of** |
| | **March 28,<br>2026** | **September 27,<br>2025** |
| **Assets** | | |
| Current assets: |  |  |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents | $200156 | $174668 |
| &nbsp;&nbsp;&nbsp;Marketable securities | 48897 | 52858 |
| &nbsp;&nbsp;&nbsp;Accounts receivable, net | 95511 | 65847 |
| &nbsp;&nbsp;&nbsp;Inventories | 160840 | 171020 |
| &nbsp;&nbsp;&nbsp;Prepaids and other current assets | 34718 | 39642 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 540122 | 504035 |
| Property and equipment, net | 63038 | 72277 |
| Operating lease right-of-use assets | 43950 | 45297 |
| Goodwill | 82854 | 82854 |
| Intangible assets, net | 67741 | 75356 |
| Deferred tax assets | 10409 | 10509 |
| Other noncurrent assets | 31368 | 32950 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $839482 | $823278 |
| **Liabilities and stockholders' equity** |  |  |
| Current liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;Accounts payable | $162927 | $184109 |
| &nbsp;&nbsp;&nbsp;Accrued expenses | 66736 | 79094 |
| &nbsp;&nbsp;&nbsp;Accrued compensation | 24298 | 21331 |
| &nbsp;&nbsp;&nbsp;Deferred revenue, current | 38772 | 21771 |
| &nbsp;&nbsp;&nbsp;Other current liabilities | 48374 | 46107 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 341107 | 352412 |
| Operating lease liabilities, noncurrent | 51803 | 53288 |
| Deferred revenue, noncurrent | 59161 | 59453 |
| Deferred tax liabilities | 118 | 126 |
| Other noncurrent liabilities | 2930 | 2774 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | 455119 | 468053 |
| Commitments and contingencies (Note 7) |  |  |
| Stockholders' equity: |  |  |
| &nbsp;&nbsp;&nbsp;Common stock, $0.001 par value | 123 | 123 |
| &nbsp;&nbsp;&nbsp;&nbsp;Treasury stock | (56653) | (37398) |
| &nbsp;&nbsp;&nbsp;&nbsp;Additional paid-in capital | 486326 | 502775 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accumulated deficit | (47166) | (112078) |
| &nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive income | 1733 | 1803 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total stockholders' equity | 384363 | 355225 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities and stockholders' equity | $839482 | $823278 |

---

The accompanying notes are an integral part of these condensed consolidated financial statements.

------

**<u>[Table of contents](#i92d71685303e4745bebf668b98f078d9_7)</u>**

**SONOS, INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)**

*(unaudited, in thousands, except share and per share amounts)*

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
| | **March 28,<br>2026** | **March 29,<br>2025** | **March 28,<br>2026** | **March 29,<br>2025** |
| Revenue | $281526 | $259756 | $827189 | $810613 |
| Cost of revenue | 156877 | 146147 | 449080 | 455597 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gross profit | 124649 | 113609 | 378109 | 355016 |
| Operating expenses |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Research and development | 64134 | 77423 | 123896 | 158261 |
| &nbsp;&nbsp;&nbsp;&nbsp;Sales and marketing | 62376 | 64210 | 127650 | 150854 |
| &nbsp;&nbsp;&nbsp;&nbsp;General and administrative | 29714 | 33200 | 57723 | 59032 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 156224 | 174833 | 309269 | 368147 |
| Operating income (loss) | (31575) | (61224) | 68840 | (13131) |
| Other income (expense), net |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest income | 1911 | 1973 | 3260 | 3834 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense | (104) | (109) | (220) | (219) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other income (expense), net | (1361) | 193 | (941) | (5836) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total other income (expense), net | 446 | 2057 | 2099 | (2221) |
| Income (loss) before provision for (benefit from) income taxes | (31129) | (59167) | 70939 | (15352) |
| Provision for (benefit from) income taxes | (2243) | 10977 | 6027 | 4555 |
| Net income (loss) | $(28886) | $(70144) | $64912 | $(19907) |
| Earnings (loss) per share: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | $(0.24) | $(0.58) | $0.54 | $(0.16) |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | $(0.24) | $(0.58) | $0.52 | $(0.16) |
| Weighted-average shares used in computing earnings (loss) per share: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | 120209712 | 119919163 | 120349630 | 120995375 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | 120209712 | 119919163 | 123651309 | 120995375 |
| Total comprehensive income (loss) |  |  |  |  |
| Net income (loss) | (28886) | (70144) | 64912 | (19907) |
| Change in foreign currency translation adjustment | (1763) | 656 | (28) | (460) |
| Net unrealized loss on marketable securities  | (59) | (33) | (42) | (117) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Comprehensive income (loss) | $(30708) | $(69521) | $64842 | $(20484) |

---

The accompanying notes are an integral part of these condensed consolidated financial statements.

------

**<u>[Table of contents](#i92d71685303e4745bebf668b98f078d9_7)</u>**

**SONOS, INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY**

*(unaudited, in thousands, except share amounts)*

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
| | **March 28,<br>2026** | **March 29,<br>2025** | **March 28,<br>2026** | **March 29,<br>2025** |
| **Total stockholders' equity, beginning balances** | $443326 | $469127 | $355225 | $428620 |
| Common stock |  |  |  |  |
| &nbsp;&nbsp;Beginning balances | $124 | $125 | $123 | $123 |
| &nbsp;&nbsp;&nbsp;Issuance of common stock pursuant to equity incentive plans | 1 | 2 | 4 | 4 |
| &nbsp;&nbsp;&nbsp;Retirement of treasury stock | (2) | (3) | (4) | (3) |
| &nbsp;&nbsp;Ending balances | $123 | $124 | $123 | $124 |
| Additional paid-in capital |  |  |  |  |
| &nbsp;&nbsp;Beginning balances | $505709 | $521121 | $502775 | $498245 |
| &nbsp;&nbsp;&nbsp;Issuance of common stock pursuant to equity incentive plans | 1905 | 242 | 15134 | 2650 |
| &nbsp;&nbsp;&nbsp;Retirement of treasury stock | (36152) | (36803) | (61639) | (41669) |
| &nbsp;&nbsp;&nbsp;Stock-based compensation expense | 14864 | 23245 | 30056 | 48579 |
| &nbsp;&nbsp;Ending balances | $486326 | $507805 | $486326 | $507805 |
| Treasury stock |  |  |  |  |
| &nbsp;&nbsp;Beginning balances | $(47782) | $(48504) | $(37398) | $(17096) |
| &nbsp;&nbsp;&nbsp;Retirement of treasury stock | 36155 | 36806 | 61644 | 41672 |
| &nbsp;&nbsp;&nbsp;Repurchase of common stock, including excise tax and commission | (39970) | (33033) | (64970) | (60264) |
| &nbsp;&nbsp;&nbsp;Repurchase of common stock related to shares withheld for tax in connection with vesting of stock awards | (5056) | (7203) | (15929) | (16246) |
| &nbsp;&nbsp;Ending balances | $(56653) | $(51934) | $(56653) | $(51934) |
| Accumulated deficit |  |  |  |  |
| &nbsp;&nbsp;Beginning balances | $(18280) | $(697) | $(112078) | $(50934) |
| &nbsp;&nbsp;&nbsp;Net income (loss) | (28886) | (70144) | 64912 | (19907) |
| &nbsp;&nbsp;Ending balances | $(47166) | $(70841) | $(47166) | $(70841) |
| Accumulated other comprehensive income (loss) |  |  |  |  |
| &nbsp;&nbsp;Beginning balances | $3555 | $(2918) | $1803 | $(1718) |
| &nbsp;&nbsp;&nbsp;Change in foreign currency translation adjustment | (1763) | 656 | (28) | (460) |
| &nbsp;&nbsp;&nbsp;Unrealized loss on investments | (59) | (33) | $(42) | $(117) |
| &nbsp;&nbsp;Ending balances | $1733 | $(2295) | $1733 | $(2295) |
| **Total stockholders' equity, ending balances** | $384363 | $382859 | $384363 | $382859 |
| Common stock shares: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Beginning balances | 123866176 | 124729283 | 122881915 | 123046510 |
| &nbsp;&nbsp;&nbsp;&nbsp;Issuance of common stock pursuant to equity incentive plans | 1102431 | 1573594 | 4013970 | 3677577 |
| &nbsp;&nbsp;&nbsp;&nbsp;Retirement of treasury stock | (2143768) | (2542709) | (4071046) | (2963919) |
| &nbsp;&nbsp;&nbsp;Ending balances | 122824839 | 123760168 | 122824839 | 123760168 |
| Treasury stock shares: |  |  |  |  |
| &nbsp;&nbsp;Beginning balances | (3005292) | (3404233) | (2788802) | (1282734) |
| &nbsp;&nbsp;&nbsp;Retirement of treasury stock | 2143768 | 2542709 | 4071046 | 2963919 |
| &nbsp;&nbsp;&nbsp;Repurchase of common stock | (2526616) | (2282549) | (4014842) | (4167203) |
| &nbsp;&nbsp;&nbsp;Repurchase of common stock related to shares withheld for tax in connection with vesting of stock awards | (310346) | (548209) | (965888) | (1206264) |
| &nbsp;&nbsp;Ending balances | (3698486) | (3692282) | (3698486) | (3692282) |

---

The accompanying notes are an integral part of these condensed consolidated financial statements.

------

**<u>[Table of contents](#i92d71685303e4745bebf668b98f078d9_7)</u>**

**SONOS, INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS**

*(unaudited, in thousands)*

---

| | | |
|:---|:---|:---|
| | **Six Months Ended** | **Six Months Ended** |
| | **March 28,<br>2026** | **March 29,<br>2025** |
| **Cash flows from operating activities** | | |
| Net income (loss) | $64912 | $(19907) |
| &nbsp;&nbsp;Adjustments to reconcile net income (loss) to net cash provided by operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;Stock-based compensation expense | 30056 | 45436 |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization | 25862 | 32778 |
| &nbsp;&nbsp;&nbsp;Restructuring and other charges | 848 | 4889 |
| &nbsp;&nbsp;&nbsp;Provision for excess and obsolete inventory | 343 | (143) |
| &nbsp;&nbsp;&nbsp;Deferred income taxes | 72 | 997 |
| &nbsp;&nbsp;&nbsp;Other | 4402 | 1528 |
| &nbsp;&nbsp;&nbsp;Foreign currency transaction loss (gain) | 1222 | (72) |
| &nbsp;&nbsp;&nbsp;&nbsp;Changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable | (31660) | 4702 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | 9837 | 92615 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other assets | 4796 | 1328 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and accrued expenses | (33297) | (83634) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued compensation | 3522 | 10456 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred revenue | 16993 | (257) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other liabilities | 25 | 5791 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by operating activities | 97933 | 96507 |
| **Cash flows from investing activities** |  |  |
| Purchases of marketable securities | (25219) | (25900) |
| Purchases of property and equipment | (10734) | (18662) |
| Maturities of marketable securities | 29140 | 27400 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in investing activities | (6813) | (17162) |
| **Cash flows from financing activities** |  |  |
| Payments for repurchase of common stock | (65121) | (60602) |
| Payments for repurchase of common stock related to shares withheld for tax in connection with vesting of stock awards | (15929) | (16246) |
| Proceeds from exercise of stock options | 15138 | 2654 |
| Payments for debt issuance costs | (780) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in financing activities | (66692) | (74194) |
| Effect of exchange rate changes on cash and cash equivalents | 1060 | (1725) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net increase in cash and cash equivalents | 25488 | 3426 |
| **Cash and cash equivalents** |  |  |
| Beginning of period | 174668 | 169732 |
| End of period | $200156 | $173158 |
| **Supplemental disclosure** |  |  |
| Cash paid for interest | $123 | $126 |
| Cash paid for taxes, net of refunds | $3346 | $16493 |
| Cash paid for amounts included in the measurement of lease liabilities, net of tenant improvement reimbursements received | $4473 | $1149 |
| **Supplemental disclosure of non-cash investing and financing activities** |  |  |
| Purchases of property and equipment in accounts payable and accrued expenses | $4588 | $1311 |
| Right-of-use assets obtained in exchange for new operating lease liabilities | $1829 | $1491 |
| Excise tax on share repurchases, accrued but not paid | $130 | $264 |

---

The accompanying notes are an integral part of these condensed consolidated financial statements.

------

**<u>[Table of contents](#i92d71685303e4745bebf668b98f078d9_7)</u>**

**SONOS, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*(unaudited)*

**1. Business Overview and Basis of Presentation**

***Description of business***

The Company's products are sold through third-party physical retailers, including custom installers of home audio systems, select e-commerce retailers, and its website, sonos.com. The Company's products are distributed in over 60 countries through its wholly owned subsidiaries: Sonos Europe B.V. in the Netherlands, Beijing Sonos Technology Co. Ltd. in China, Sonos Japan GK in Japan, and Sonos Australia Pty Ltd. in Australia.

***Basis of presentation and preparation***

The accompanying condensed consolidated financial statements are unaudited. The condensed consolidated balance sheet as of September 27, 2025, has been derived from the audited consolidated financial statements of the Company.

The accompanying condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America ("U.S. GAAP") for interim financial information and the applicable rules and regulations of the Securities and Exchange Commission ("SEC"). Accordingly, they do not include all the information and footnotes required by U.S. GAAP for annual financial statements. They should be read in conjunction with the consolidated financial statements and notes thereto contained in the Company's Annual Report on Form 10-K for the fiscal year ended September 27, 2025, (the "Annual Report"), filed with the SEC on November 14, 2025.

In management's opinion, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of only normal recurring adjustments, necessary for the fair statement of the Company's financial position, its results of operations, and its cash flows for the interim periods presented. The results of operations for the three and six months ended March 28, 2026, are not necessarily indicative of the results to be expected for the full fiscal year or any other period.

The Company operates on a 52- week or 53- week fiscal year ending on the Saturday nearest September 30 each year. The Company's fiscal year is divided into four quarters of 13 weeks, each beginning on a Sunday and containing two 4-week periods followed by a 5-week period. An additional week is included in the fourth fiscal quarter approximately every five years to realign fiscal quarters with calendar quarters. This last occurred in the fourth quarter of the Company's fiscal year ended October 3, 2020, and will reoccur in the fiscal year ending October 3, 2026. The six months ended March 28, 2026 and March 29, 2025, spanned 26 weeks each. As used in this Quarterly Report on Form 10-Q, "fiscal 2026" refers to the fiscal year ending October 3, 2026, "fiscal 2025" refers to the fiscal year ended September 27, 2025, and "fiscal 2024" refers to the fiscal year ended September 28, 2024.

***Use of estimates and judgments***

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and judgments that affect the amounts reported and disclosed in the condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. On an ongoing basis, the Company evaluates its estimates and judgments compared to historical experience and expected trends.

***Segment Information***

The Company operates as one operating segment as it only reports aggregate financial information on a consolidated basis, accompanied by disaggregated information about revenue by geographic region and product category, to its Chief Executive Officer, who is the Company's Chief Operating Decision Maker ("CODM"). The CODM reviews financial information on a consolidated basis for purposes of making operating decisions, allocating resources, and evaluating financial performance. The CODM uses consolidated net income (loss) to measure segment profit or loss and make key operating decisions, such as allocation of the budget and monitoring budget versus actual results.

Significant expenses within net income (loss) include cost of revenue, research and development, sales and marketing, and general and administrative, which are each separately presented on the Company's condensed consolidated statements of operations and comprehensive income. Other segment items include interest income, interest expense, other income (expense), and provision for (benefit

------

**<u>[Table of contents](#i92d71685303e4745bebf668b98f078d9_7)</u>**

**SONOS, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*(unaudited)*

from) income taxes, which are also each separately presented on the Company's condensed consolidated statements of operations and comprehensive income (loss). The CODM does not evaluate segment performance or allocate resources using asset information.

**2. Summary of Significant Accounting Policies** 

There have been no changes in the Company's significant accounting policies, recently adopted accounting pronouncements, or recent accounting pronouncements pending adoption from those disclosed in the Annual Report, except as noted below.

***Recent accounting pronouncements pending adoption*** 

In December 2025, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2025-11, Interim Reporting (Topic 270): Narrow-Scope Improvements. This update provides clarifications intended to improve the consistency and usability of interim disclosure requirements, including a comprehensive listing of required interim disclosures and a new disclosure principle for reporting material events occurring after the most recent annual reporting period. The amendments do not change the underlying objectives of interim reporting but are designed to enhance clarity in application. The amendments are effective for interim reporting periods within annual reporting periods beginning after December 15, 2027. The amendments may be applied retrospectively or prospectively, with early adoption permitted. The Company is currently evaluating the pronouncement to determine the impact it may have on the Company's consolidated financial statements and related disclosures.

In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures ("ASU 2023-09"). This update includes amendments that further enhance income tax disclosures, primarily through standardization and disaggregation of rate reconciliation categories and income taxes paid by jurisdiction. The amendments will be effective for the Company's fiscal year ending October 3, 2026. The Company expects adoption of ASU 2023-09 to result in expanded income tax disclosures. The amendments only impact disclosures and are not expected to have an impact on the Company's financial condition and results of operations.

**3. Financial Instruments**

The carrying values of the Company's accounts receivable and accounts payable, approximate their fair values due to the short period of time to maturity or repayment. The Company utilizes the following fair value hierarchy to establish priorities of the inputs used to measure fair value:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 1: Quoted prices in active markets for identical assets or liabilities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 2: Observable inputs other than quoted market prices included in Level 1, such as quoted prices for similar assets or liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.

The following table summarizes cash, cash equivalents and marketable securities by investment category as of March 28, 2026 and September 27, 2025:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **March 28, 2026** | **March 28, 2026** | **March 28, 2026** | **March 28, 2026** | **March 28, 2026** | **March 28, 2026** |
| | **Amortized Cost** | **Unrealized Gain** | **Unrealized Loss** | **Estimated Fair Value** | **Cash and Cash Equivalents** | **Marketable Securities** |
| Cash | $96487 | $— | $— | $96487 | $96487 | $— |
| **Level 1:** |  |  |  |  |  |  |
| Money market funds | 103669 |  |  | 103669 | 103669 |  |
| Subtotal | 103669 |  |  | 103669 | 103669 |  |
| **Level 2:** |  |  |  |  |  |  |
| U.S. Treasury securities | 48916 | 13 | (32) | 48897 |  | 48897 |
| Subtotal | 48916 | 13 | (32) | 48897 |  | 48897 |
| Total | $249072 | $13 | $(32) | $249053 | $200156 | $48897 |

---

------

**<u>[Table of contents](#i92d71685303e4745bebf668b98f078d9_7)</u>**

**SONOS, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*(unaudited)*

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **September 27, 2025** | **September 27, 2025** | **September 27, 2025** | **September 27, 2025** | **September 27, 2025** | **September 27, 2025** |
| | **Amortized Cost** | **Unrealized Gain** | **Unrealized Loss** | **Estimated Fair Value** | **Cash and Cash Equivalents** | **Marketable Securities** |
| Cash | $158556 | $— | $— | $158556 | $158556 | $— |
| **Level 1:** |  |  |  |  |  |  |
| Money market funds | 16112 |  |  | 16112 | 16112 |  |
| Subtotal | 16112 |  |  | 16112 | 16112 |  |
| **Level 2:** |  |  |  |  |  |  |
| U.S. Treasury securities | 52834 | 32 | (8) | 52858 |  | 52858 |
| Subtotal | 52834 | 32 | (8) | 52858 |  | 52858 |
| Total | $227502 | $32 | $(8) | $227526 | $174668 | $52858 |

---

*Marketable securities* 

As of March 28, 2026, the Company held no securities with original maturities exceeding one year. There were no realized gains or losses on sales of marketable securities during the three and six months ended March 28, 2026.

For securities in an unrealized loss position, the Company does not intend to sell the securities, and it is more-likely-than-not that it will not be required to sell before recovery of their amortized cost basis. The Company evaluated whether the decline in fair value resulted from credit losses or other factors and concluded these amounts were related to temporary fluctuations in value of the securities and were due primarily to changes in interest rates and market conditions of the underlying securities. Accordingly, an allowance for credit losses was deemed unnecessary for these securities as of March 28, 2026.

Accrued interest receivable related to our marketable securities was insignificant as of March 28, 2026. No accrued interest receivables were written off during the three and six months ended March 28, 2026.

**4. Revenue and Geographic Information**

***Disaggregation of revenue***

Revenue includes the applicable service revenue for unspecified software upgrades and cloud-based services attributable to each region and is as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
| | **March 28,<br>2026** | **March 29,<br>2025** | **March 28,<br>2026** | **March 29,<br>2025** |
| **(In thousands)** | | | | |
| Americas | $180608 | $176802 | $509485 | $501385 |
| Europe, Middle East and Africa ("EMEA") | 83161 | 68785 | 272602 | 266397 |
| Asia Pacific ("APAC") | 17757 | 14169 | 45102 | 42831 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total revenue | $281526 | $259756 | $827189 | $810613 |

---

------

**<u>[Table of contents](#i92d71685303e4745bebf668b98f078d9_7)</u>**

**SONOS, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*(unaudited)*

Revenue includes the applicable service revenue for unspecified software upgrades and cloud-based services attributable to each country and is as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
| | **March 28,<br>2026** | **March 29,<br>2025** | **March 28,<br>2026** | **March 29,<br>2025** |
| **(In thousands)** | | | | |
| United States | $171277 | $167102 | $476301 | $461732 |
| Other countries | 110249 | 92654 | 350888 | 348881 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total revenue | $281526 | $259756 | $827189 | $810613 |

---

Revenue by product category also includes the applicable service revenue for unspecified software upgrades and cloud-based services attributable to each product category and is as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
| | **March 28,<br>2026** | **March 29,<br>2025** | **March 28,<br>2026** | **March 29,<br>2025** |
| **(In thousands)** | | | | |
| Sonos speakers | $210018 | $194519 | $669258 | $661661 |
| Sonos system products | 52411 | 50540 | 117469 | 110814 |
| Partner products and other revenue | 19097 | 14697 | 40462 | 38138 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total revenue | $281526 | $259756 | $827189 | $810613 |

---

**5. Balance Sheet Components**

***Accounts receivable, net***

Accounts receivable, net consist of the following:

---

| | | |
|:---|:---|:---|
| | **March 28,<br>2026** | **September 27,<br>2025** |
| **(In thousands)** | | |
| Accounts receivable | $139089 | $131945 |
| Allowance for credit losses | (3433) | (2900) |
| Allowance for sales incentives | (40145) | (63198) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable, net of allowances | $95511 | $65847 |

---

***Inventories***

Inventories consist of the following:

---

| | | |
|:---|:---|:---|
| | **March 28,<br>2026** | **September 27,<br>2025** |
| **(In thousands)** | | |
| Finished goods | $144238 | $153485 |
| Component parts | 16602 | 17535 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | $160840 | $171020 |

---

As of March 28, 2026 and September 27, 2025, the Company's reserves for excess and obsolete inventory were $40.5 million and $41.2 million, respectively.

------

**<u>[Table of contents](#i92d71685303e4745bebf668b98f078d9_7)</u>**

**SONOS, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*(unaudited)*

***Property and equipment***

Property and equipment net of accumulated depreciation were as follows:

---

| | | |
|:---|:---|:---|
| | **March 28,<br>2026** | **September 27,<br>2025** |
| **(In thousands)** | | |
| Property and equipment | $279069 | $269938 |
| Less: accumulated depreciation | (216031) | (197661) |
| Property and equipment, net | $63038 | $72277 |

---

***Intangible assets***

The following table reflects the changes in the net carrying amount of the components of intangible assets associated with the Company's acquisition activity:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **March 28, 2026** | **March 28, 2026** | **March 28, 2026** | **March 28, 2026** | **March 28, 2026** |
|  | **Gross Carrying Amount** | **Accumulated Amortization** | **Foreign Currency Translation** | **Net Carrying Value** | **Weighted-Average Remaining Life** <br>**(In years)** |
| **(In thousands, except weighted-average remaining life)** | | | | | |
| Trade name | $451 | $(304) | $12 | $159 | 2.00 |
| Technology-based | 94419 | (26837) | - | 67582 | 5.25 |
| Total intangible assets | $94870 | $(27141) | $12 | $67741 | 5.24 |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **September 27, 2025** | **September 27, 2025** | **September 27, 2025** | **September 27, 2025** | **September 27, 2025** |
| | **Gross Carrying Amount** | **Accumulated Amortization** | **Foreign Currency Translation** | **Net Carrying Value** | **Weighted-Average Remaining Life<br>(In years)** |
| (In thousands, except weighted-average remaining life) |  |  |  |  |  |
| Trade name | $451 | $(264) | $16 | $203 | 2.50 |
| Technology-based | 94419 | (19266) | - | 75153 | 5.73 |
| Total intangible assets | $94870 | $(19530) | $16 | $75356 | 5.73 |

---

The following table summarizes the estimated future amortization expense of the Company's intangible assets as of March 28, 2026:

---

| | |
|:---|:---|
| **Fiscal years ending** | **Future Amortization Expense** |
| **(In thousands)** | |
| Remainder of fiscal 2026 | $5972 |
| 2027 | 13568 |
| 2028 | 13450 |
| 2029 | 12453 |
| 2030 | 10539 |
| 2031 and thereafter | 11759 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total future amortization expense | $67741 |

---

***Cloud computing arrangements***

Capitalized costs to implement cloud computing arrangements net of accumulated amortization are reported as a component of other noncurrent assets on the Company's condensed consolidated balance sheets and were as follows:

------

**<u>[Table of contents](#i92d71685303e4745bebf668b98f078d9_7)</u>**

**SONOS, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*(unaudited)*

---

| | | |
|:---|:---|:---|
| | **March 28,<br>2026** | **September 27,<br>2025** |
| **(In thousands)** | | |
| Cloud computing implementation costs | $27411 | $27411 |
| Less: accumulated amortization | (15434) | (13320) |
| Cloud computing implementation costs, net | $11977 | $14091 |

---

Amortization expense for implementation costs for cloud-based computing arrangements for the three months ended March 28, 2026 and March 29, 2025, were $1.1 million and $0.9 million, respectively. Amortization expense for implementation costs for cloud-based computing arrangements for the six months ended March 28, 2026 and March 29, 2025, were $2.1 million and $1.7 million, respectively.

***Accrued expenses***

Accrued expenses included the following:

---

| | | |
|:---|:---|:---|
| | **March 28,<br>2026** | **September 27,<br>2025** |
| **(In thousands)** | | |
| Accrued inventory and supply chain costs | $33442 | $37780 |
| Accrued general and administrative expenses | 10834 | 8923 |
| Accrued advertising and marketing | 8232 | 12429 |
| Accrued taxes | 6255 | 10133 |
| Accrued product development | 3543 | 5912 |
| Other accrued payables | 4430 | 3917 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total accrued expenses | $66736 | $79094 |

---

***Deferred revenue***

Amounts invoiced in advance of revenue recognition are recorded as deferred revenue on the condensed consolidated balance sheets and include revenue allocated to unspecified software upgrades and cloud-based services, as well as current deferred revenue related to newly launched products sold to resellers not recognized as revenue until reaching the date of general availability.

The following table presents the changes in the Company's deferred revenue:

---

| | | |
|:---|:---|:---|
| | **Six Months Ended** | **Six Months Ended** |
| | **March 28,<br>2026** | **March 29,<br>2025** |
| **(In thousands)** | | |
| Deferred revenue, beginning of period | $81225 | $82877 |
| Recognition of revenue included in beginning of period deferred revenue | (11186) | (12229) |
| Revenue deferred, net of revenue recognized on contracts in the respective period<sup>(1)</sup> | 27894 | 10842 |
| Deferred revenue, end of period | $97933 | $81490 |

---

<sup>(1)</sup> Deferred revenue included amounts related to newly launched products sold to resellers for which revenue is deferred until the products reach general availability, which contributed to the increase during the period.

The Company expects the following recognition of deferred revenue as of March 28, 2026:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **For the fiscal years ending** | **For the fiscal years ending** | **For the fiscal years ending** | **For the fiscal years ending** | **For the fiscal years ending** | |
| | **Remainder of 2026** | **2027** | **2028** | **2029** | **2030 and <br>Beyond** | **Total** |
| **(In thousands)** |  |  |  |  |  |  |
| Deferred revenue expected to be recognized | $28494 | $19878 | $16769 | $13214 | $19578 | $97933 |

---

------

**<u>[Table of contents](#i92d71685303e4745bebf668b98f078d9_7)</u>**

**SONOS, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*(unaudited)*

***Other current liabilities***

Other current liabilities consist of the following:

---

| | | |
|:---|:---|:---|
| | **March 28,<br>2026** | **September 27,<br>2025** |
| **(In thousands)** | | |
| Reserve for returns | $22600 | $20383 |
| Warranty liability | 9968 | 10002 |
| Short-term operating lease liabilities | 6880 | 6335 |
| Other | 8926 | 9387 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total other current liabilities | $48374 | $46107 |

---

The following table presents the changes in the Company's warranty liability:

---

| | | |
|:---|:---|:---|
| | **March 28,<br>2026** | **March 29,<br>2025** |
| **(In thousands)** | | |
| Warranty liability, beginning of period | $10002 | $10565 |
| Provision for warranties issued during the period | 4575 | 7428 |
| Settlements of warranty claims during the period | (4609) | (8019) |
| Warranty liability, end of period | $9968 | $9974 |

---

**6. Debt** 

On October 13, 2021, the Company entered into a Revolving Credit Agreement (the "Revolving Credit Agreement") which was amended in October 2025 ("Amendment No. 2") with JPMorgan Chase Bank, N.A., KeyBank National Association and Goldman Sachs Bank USA. Amendment No. 2 provides for (i) a five-year senior secured revolving credit facility in the amount of up to $80.0 million and (ii) an uncommitted incremental facility subject to certain conditions. Proceeds are to be used for working capital and general corporate purposes. The facility may be drawn as an Alternative Base Rate Loan (at 1.00% plus an applicable margin) or Term Benchmark Loan (SOFR plus an applicable margin). The Company must also pay (i) an unused commitment fee ranging from 0.200% to 0.275% per annum of the average daily unused portion of the aggregate revolving credit commitment under the agreement and (ii) a per annum fee equal to the applicable margin over SOFR multiplied by the aggregate face amount of outstanding letters of credit. As of March 28, 2026, the Company did not have any outstanding borrowings and had $2.4 million in undrawn letters of credit that reduce the availability under the Revolving Credit Agreement.

The Company's obligations under the Revolving Credit Agreement are secured by substantially all of its assets. The Revolving Credit Agreement contains customary representations and warranties, customary affirmative and negative covenants, a financial covenant that is tested quarterly and requires the Company to maintain a certain consolidated leverage ratio, and customary events of default. As of March 28, 2026, the Company was in compliance with all financial covenants under the Revolving Credit Agreement.

**7. Commitments and Contingencies**

***Legal proceedings***

From time to time, the Company is involved in legal proceedings in the ordinary course of business, including claims relating to employee relations, business practices, and patent infringement. Litigation can be expensive and disruptive to normal business operations. Moreover, the results of complex legal proceedings are difficult to predict, and the Company's view of these matters may change in the future as the litigation and events related thereto unfold. The Company expenses legal fees as incurred. The Company records a provision for contingent losses when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. An unfavorable outcome to any legal matter, if material, could have an adverse effect on the Company's operations or its financial position, liquidity or results of operations.

*The Company's Lawsuits Against Google:*

On January 7, 2020, the Company filed a complaint with the U.S. International Trade Commission ("ITC") against Alphabet Inc. ("Alphabet") and Google LLC ("Google") and a counterpart lawsuit in the U.S. District Court for the Central District of California against Google. The complaint and lawsuit each allege infringement by Alphabet and Google of certain Sonos patents related to its smart speakers

------

**<u>[Table of contents](#i92d71685303e4745bebf668b98f078d9_7)</u>**

**SONOS, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*(unaudited)*

and related technology. The counterpart lawsuit was stayed pending completion of the ITC investigation and appeal thereof. The ITC concluded its investigation in January 2022, finding all five of the Company's asserted patents to be valid and infringed by Google, and further finding that one redesign per patent proposed by Google would avoid infringement. The ITC issued a limited exclusion order and a cease-and-desist order with respect to Google's infringing products. The Company and Google each appealed the ITC's determination, which was upheld in its entirety by the appeals court. The stay in the counterpart lawsuit has been lifted. Google moved to file counterclaims on two of its own patents related to device setup and the court has added those patents to the case. No trial date has been set.

On September 29, 2020, the Company filed another lawsuit against Google alleging infringement of additional Sonos patents and seeking monetary damages and other non-monetary relief. A jury trial was held in May 2023, which found one Sonos patent to be infringed and another Sonos patent not infringed, and returned an award of $32.5 million based on a royalty rate of $2.30 per infringing unit. After trial, the court held Sonos' patents unenforceable under the doctrine of prosecution laches and invalid as a result of amendments made during prosecution. In September 2025, the Federal Circuit overturned the lower court decision that had invalidated the jury verdict against Google, and is now set to decide the post-trial motions, including the Company's motion for injunctive relief and additional damages.

*Google's Lawsuits Against the Company:* 

On June 11, 2020, Google filed a lawsuit in the U.S. District Court for the Northern District of California against the Company alleging infringement by the Company of five Google patents and seeking monetary damages and other non-monetary relief. All five of these patents have since been found invalid or non-infringed by the Court or by the U.S. Patent and Trademark Office or have been withdrawn from the case by Google. The Court has now entered final judgment for Sonos and against Google. Google has appealed the non-infringement rulings.

On August 8, 2022, Google filed two complaints with the ITC against the Company and two counterpart lawsuits in the Northern District of California against the Company, collectively alleging infringement by the Company of seven Google patents generally related to wireless charging, device setup, and voice control, and seeking monetary damages and other non-monetary relief. The counterpart lawsuits are stayed pending completion of the ITC investigations. In the first ITC investigation, the ITC terminated the investigation as to one Google patent as a result of the expiration of that Google patent and determined the other two Google patents to be invalid as indefinite, thus concluding the first investigation. Google has appealed this first ITC determination. The Company has also initiated Inter Partes Reviews at the U.S. Patent and Trademark Office ("USPTO") against these two remaining Google patents, which resulted in the USPTO invalidating these two Google patents. Google has appealed this determination, which is awaiting a decision. The second ITC investigation concluded in December 2023 with a final determination of no violation by the Company. Google did not appeal this determination.

*Implicit* 

On March 10, 2017, Implicit, LLC ("Implicit") filed a patent infringement action in the United States District Court, District of Delaware against the Company. Implicit asserted that the Company has infringed on certain claims of two patents in this case. The Company denied the allegations. The claims at issue have been held unpatentable by the USPTO. Implicit appealed this ruling, but on March 9, 2026, the Federal Circuit rejected Implicit's appeal and affirmed the PTO's ruling. Implicit has filed for en banc review of the adverse appellate ruling. Accordingly, no range of loss associated with this matter is probable as of March 28, 2026.

The Company is involved in certain other litigation matters not listed above but does not consider these matters to be material either individually or in the aggregate at this time. The Company's view of the matters not listed may change in the future as the litigation and events related thereto unfold.

On February 20, 2026, the U.S. Supreme Court ruled that certain tariffs imposed under the International Emergency Economic Powers Act (IEEPA) were invalid. To date, the Company has paid approximately $40 million in IEEPA-related tariffs that may now be recoverable. Due to uncertainties regarding the timing and ultimate receipt of these funds, no receivable has been recorded. The Company will recognize any recoveries as a reduction to cost of revenue in the period they become realized or realizable.

**8. Stockholders' Equity** 

On February 24, 2025, the Board of Directors (the "Board") authorized a common stock repurchase program of up to $150.0 million. During the six months ended March 28, 2026, the Company repurchased 4,014,842 shares for an aggregate purchase price of $64.8 million and at an average price of $16.14 per share under the repurchase program. Aggregate purchase price and average price per share exclude commission and excise tax. As of March 28, 2026, the Company had $64.8 million available for share repurchases under the share repurchase program. The Company's share repurchases in excess of issuances are subject to a 1% excise tax enacted by the Inflation Reduction Act. Any excise tax incurred is recognized as part of the cost basis of the shares acquired in the condensed consolidated statements of equity.

------

**<u>[Table of contents](#i92d71685303e4745bebf668b98f078d9_7)</u>**

**SONOS, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*(unaudited)*

Treasury stock during the six months ended March 28, 2026, included 965,888 shares withheld to satisfy employees' tax withholding requirements in connection with vesting of stock awards. Additionally, during the six months ended March 28, 2026, the Company retired 4,071,046 shares of treasury stock.

**9. Stock-based Compensation** 

***2018 Equity Incentive Plan***

In July 2018, the Board adopted the 2018 Equity Incentive Plan (the "2018 Plan").

***Stock options***

The summary of the Company's stock option activity is as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Number of Options** | **Weighted-Average Exercise Price** | **Weighted-Average Remaining Contractual Term** | **Aggregate Intrinsic Value** |
|  | | | **(In years)** | **(In thousands)** |
| Outstanding at September 27, 2025 | 5544885 | $14.28 | 1.5 | $5850 |
| Exercised | (1065505) | $14.21 |  |  |
| Forfeited / expired | (25342) | $14.79 |  |  |
| Outstanding at March 28, 2026 | 4454038 | $14.29 | 1.1 | $322 |

---

As of March 28, 2026 and September 27, 2025, all outstanding stock options have vested and the Company had no unrecognized stock-based compensation expense related to stock options.

***Restricted stock units ("RSU")***

Pursuant to the 2018 Plan, the Company issues RSUs to employees and directors. The summary of the Company's RSU activity is as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **Number of Units**  | **Weighted-Average Grant Date Fair <br>Value** | **Aggregate Intrinsic Value** |
| | | | **(In thousands)** |
| **Outstanding at September 27, 2025** | 8777387 | $12.96 | $134294 |
| Granted | 2166007 | $16.40 |  |
| Released | (2924689) | $13.49 |  |
| Forfeited | (411141) | $13.32 |  |
| **Outstanding at March 28, 2026** | 7607564 | $13.72 | $96616 |

---

As of March 28, 2026 and September 27, 2025, the Company had $77.0 million and $78.1 million of unrecognized stock-based compensation expense related to RSUs, which are expected to be recognized over weighted-average periods of 2.4 years and 2.3 years, respectively.

***Performance stock units ("PSU")***

Pursuant to the 2018 Plan, the Company grants PSUs that vest based on both service and performance conditions. PSUs are granted at a target number of units, with the actual number of shares earned at the end of the performance period ranging above or below target based on the level of achievement of specified performance goals.

Beginning in fiscal 2026, PSU awards may include a combination of financial performance metrics and market-based conditions, such as relative total shareholder return ("TSR"). For awards with market-based conditions, grant-date fair value reflects the impact of those conditions and is estimated using a Monte Carlo simulation model.

Compensation expense for PSUs with market-based conditions is recognized over the requisite service period regardless of whether the market condition is ultimately achieved, provided the service condition is satisfied. Compensation expense for PSUs with only

------

**<u>[Table of contents](#i92d71685303e4745bebf668b98f078d9_7)</u>**

**SONOS, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*(unaudited)*

performance conditions is recognized based on the probability of achieving the specified performance goals, with cumulative adjustments recorded to reflect changes in expected achievement, and ultimately reflects the number of awards that vest based on actual performance.

The following table summarizes the weighted-average assumptions used in calculating compensation expense of the Company's PSUs with market-based conditions:

---

| | |
|:---|:---|
| | **March 28,<br>2026** |
| Remaining performance period at grant date | 2.23 |
| Volatility | 44.51% |
| Risk-free rate | 3.48% |
| Fair value | $22.67 |

---

The summary of the Company's PSU activity is as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **Number of Units**  | **Weighted-Average Grant Date Fair <br>Value** | **Aggregate Intrinsic Value** |
| | | | **(In thousands)** |
| **Outstanding at September 27, 2025** | 480538 | $14.11 | $7352 |
| Granted | 750670 | $19.00 |  |
| Released | (23776) | $12.23 |  |
| Performance adjustments | (24518) | $18.65 |  |
| **Outstanding at March 28, 2026** | 1182914 | $17.16 | $15023 |

---

As of March 28, 2026 and September 27, 2025, the Company had $15.4 million and $3.3 million of unrecognized stock-based compensation expense related to PSUs, which are expected to be recognized over weighted-average periods of 1.6 years and 1.3 years, respectively.

***Stock-based compensation***

Total stock-based compensation expense by functional category was as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
|  | **March 28,<br>2026** | **March 29,<br>2025** | **March 28,<br>2026** | **March 29,<br>2025** |
| **(In thousands)** | | | | |
| Cost of revenue | $1125 | $1606 | $2452 | $2955 |
| Research and development | 5471 | 8557 | 11960 | 21872 |
| Sales and marketing | 2763 | 4027 | 5608 | 9659 |
| General and administrative | 5505 | 9055 | 10036 | 14093 |
| Total stock-based compensation expense | $14864 | $23245 | $30056 | $48579 |

---

**10. Income Taxes**

The Company's income tax provision and the resulting effective tax rate for interim periods is generally determined based upon its estimated annual effective tax rate ("AETR"), adjusted for the effect of discrete items arising in that quarter. The impact of such inclusions could result in a higher or lower effective tax rate during a quarter, based upon the mix and timing of actual earnings or losses versus annual projections. In each quarter, the Company updates its estimate of the AETR, and if the estimated AETR changes, a cumulative adjustment is made in that quarter.

The Company recorded an income tax benefit of $2.2 million and an income tax provision of $11.0 million for the three months ended March 28, 2026 and March 29, 2025, respectively, related to U.S. and non-U.S. income taxes. The Company recorded income tax provisions of $6.0 million and $4.6 million for the six months ended March 28, 2026 and March 29, 2025, respectively, related to U.S. and non-U.S. income taxes. The effective tax rate for the three months ended March 28, 2026 was favorably impacted by provisions of the One

------

**<u>[Table of contents](#i92d71685303e4745bebf668b98f078d9_7)</u>**

**SONOS, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*(unaudited)*

Big Beautiful Bill Act ("OBBBA"), including the repeal of the requirement to capitalize and amortize specified domestic research and experimental expenditures under Section 174 of the U.S. Internal Revenue Code. This resulted in a reduction in the Company's U.S. current tax expense with no impact to deferred tax expense as a result of the full valuation allowance maintained against the Company's net U.S. deferred tax assets. The tax provision for the three months ended March 29, 2025 primarily resulted from the application of a negative annual effective tax rate to year-to-date U.S. pre-tax loss for the quarter, which was driven in part by the capitalization of research and experimental expenditures under Section 174 and the valuation allowance maintained against U.S. deferred tax assets.

In 2021, the Organization for Economic Cooperation and Development ("OECD") released model rules for a global minimum tax ("Pillar Two Rules"), intended to ensure that large multinational enterprises are subject to an effective minimum tax rate of 15% in each jurisdiction in which they operate. Certain jurisdictions in which the Company conducts business have enacted local legislation implementing Pillar Two or equivalent minimum tax rules that apply for fiscal years beginning on or after January 1, 2024. In January 2026, the OECD released administrative guidance describing a coordinated "side-by-side" package applicable to certain U.S.-parented multinational groups for fiscal years beginning on or after January 1, 2026. Based on currently enacted legislation and available guidance, the Company does not expect the Pillar Two Rules to have a material impact on its effective tax rate for fiscal year 2026. The Company continues to monitor developments in Pillar Two legislation and guidance and will assess the impact of any legislative changes to future periods.

For the six months ended March 28, 2026, the Company concluded that a full valuation allowance on its deferred tax assets in the U.S. continued to be appropriate considering cumulative pre-tax losses in recent years and uncertainty with respect to future taxable income. Release of the valuation allowance in the U.S. would result in a benefit to the income tax provision in the period the release is recorded, which could have a material impact on net earnings. The timing and amount of the potential valuation allowance release are subject to significant management judgment, as well as prospective earnings in the U.S.

**11. Earnings (Loss) Per Share** 

Earnings (loss) per share is calculated by dividing net income (loss) by the weighted-average number of shares of common stock outstanding less shares subject to repurchase. Diluted earnings (loss) per share adjusts the basic earnings (loss) per share and the

------

**<u>[Table of contents](#i92d71685303e4745bebf668b98f078d9_7)</u>**

**SONOS, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*(unaudited)*

weighted-average number of shares of common stock outstanding for the potentially dilutive impact of stock awards, using the treasury stock method.

The following table sets forth the computation of the Company's basic and diluted earnings (loss) per share:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
| | **March 28,<br>2026** | **March 29,<br>2025** | **March 28,<br>2026** | **March 29,<br>2025** |
| **(In thousands, except share and per share data)** | | | | |
| **Numerator:** | | | | |
| Net income (loss) - basic and diluted | $(28886) | $(70144) | $64912 | $(19907) |
| **Denominator:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Weighted-average shares of common stock—basic | 120209712 | 119919163 | 120349630 | 120995375 |
| &nbsp;&nbsp;&nbsp;&nbsp;Effect of potentially dilutive stock options |  |  | 606949 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Effect of RSUs |  |  | 2454697 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Effect of PSUs |  |  | 240033 |  |
| Weighted-average shares of common stock—diluted | 120209712 | 119919163 | 123651309 | 120995375 |
| **Earnings (loss) per share:** |  |  |  |  |
| Basic | $(0.24) | $(0.58) | $0.54 | $(0.16) |
| Diluted | $(0.24) | $(0.58) | $0.52 | $(0.16) |

---

The following shares were excluded from the computation of diluted net earnings (loss) per share because their effect would have been antidilutive:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
| | **March 28,<br>2026** | **March 29,<br>2025** | **March 28,<br>2026** | **March 29,<br>2025** |
| Stock options to purchase common stock | 4519252 | 6713001 | 4224300 | 6841022 |
| Restricted stock units | 8083433 | 13555418 | 5880331 | 14659903 |
| Performance stock units | 614371 | 71790 | 246391 | 44188 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | 13217056 | 20340209 | 10351022 | 21545113 |

---

**12. Retirement Plans** 

The Company has a defined contribution 401(k) plan (the "401(k) Plan") for the Company's U.S.-based employees, as well as various defined contribution plans for its international employees. Eligible U.S. employees may make tax-deferred contributions under the 401(k) plan but are limited to the maximum annual dollar amount allowable under the Internal Revenue Code of 1986, as amended. The Company matches contributions towards the 401(k) Plan and international defined contribution plans. The Company's matching contributions totaled $2.0 million for the three months ended March 28, 2026 and March 29, 2025, respectively. The Company's matching contributions totaled $4.1 million and $4.3 million for the six months ended March 28, 2026 and March 29, 2025, respectively.

------

**<u>[Table of contents](#i92d71685303e4745bebf668b98f078d9_7)</u>**

**Item 2. Management's discussion and analysis of financial condition and results of operations**

*The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our condensed consolidated financial statements and related notes included in Part I, Item 1 of this Quarterly Report on Form 10-Q and with our audited consolidated financial statements included in our Annual Report.* 

*We operate on a 52- week or 53- week fiscal year ending on the Saturday nearest September 30 each year. Our fiscal year is divided into four quarters of 13 weeks, each beginning on a Sunday and containing two 4-week periods followed by a 5-week period. An additional week is included in the fourth fiscal quarter approximately every five years to realign fiscal quarters with calendar quarters.* 

***Forward-Looking Statements***

*This Quarterly Report on Form 10-Q contains forward-looking statements. All statements other than statements of historical facts contained in this Quarterly Report on Form 10-Q, including statements regarding future operations and performance, are forward-looking statements. In some cases, forward-looking statements may be identified by words such as "believe," "may," "will," "estimate," "continue," "anticipate," "intend," "could," "would," "expect," "objective," "plan," "potential," "seek," "grow," "target," "if," and similar expressions intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and trends that we believe may affect our financial condition, results of operations, business strategy, short-term and long-term business operations, objectives, restructuring efforts, cost initiatives, timing of certain tax impacts and financial needs. These forward-looking statements are subject to a number of risks, uncertainties and assumptions, including those described in the section titled "Risk Factors" set forth in Part I, Item 1A of the Annual Report and in our other SEC filings. Moreover, we operate in a very competitive and rapidly changing environment. New risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties and assumptions, the future events and trends discussed in this Quarterly Report on Form 10-Q may not occur and actual results may differ materially and adversely from those anticipated or implied in the forward-looking statements. You should read this Quarterly Report on Form 10-Q with the understanding that our actual future results, levels of activity, performance and events and circumstances may be materially different from what we expect. Except as required by law, we do not undertake any obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.*

***Overview***

Sonos is a leading audio company dedicated to elevating life through sound. Since pioneering multi-room wireless audio in 2005, Sonos has built a system that unites every dimension of sound - music, movies, stories and conversations - into one connected platform. The portfolio includes home theater speakers, components, plug-in and portable speakers, and headphones that compound in value with every room and device its customers add. Known for exceptional sound, thoughtful design, ease of use and seamless access to the world's audio content, Sonos is trusted by more than 17 million households in 60+ countries around the world.

We are building on the strong foundation established during our transformational year in fiscal 2025. With Tom Conrad now in place as our Chief Executive Officer we are well-positioned to continue building upon the improvements we have made to our software products and operational efficiency. Under Mr. Conrad's direction, we have restored our software with reliability now exceeding historical levels, reorganized our operations to improve our efficiency and effectiveness and recommitted to delivering the kind of premium experience our customers expect. We recommitted to new product introductions, including the announcement of Amp Multi in January 2026, followed by Sonos Play™ and Sonos Era 100™ SL in March 2026. With every new product, software feature and integration, the Sonos platform becomes more powerful, provides greater value to our customers, and further strengthens as the differentiated system for connected home audio. Additionally, we are refining our go-to-market strategy around a full-funnel brand architecture designed to align our long-term brand narrative with a consistent messaging system.

Our cost transformation initiative, which began in fiscal 2024, has delivered meaningful results. The organizational restructuring we completed—including workforce reductions of 6% in August 2024 and 12% in February 2025—has created a more streamlined, agile organization. We remain focused on transformation efforts to continually improve both our operational efficiency and effectiveness. Additionally, during the third quarter of fiscal 2025, we began the process of exiting a partnership with one of our contract manufacturers to consolidate and improve supply chain efficiency. We completed the operational exit with minimal disruption to our business during the second quarter of fiscal 2026. We continue to maintain diversified contract manufacturing partnerships.

**Macroeconomic Conditions and Other Factors Affecting our Business**

Our business has been, and may continue to be, adversely impacted by the potential expansion of tariffs on goods imported into the U.S., as well as any retaliatory tariffs or policies enacted in other countries or any "trade wars." In addition, we have been and may continue to be affected by the increases in demand for memory chips and other components caused by the build out of new AI technologies

------

**<u>[Table of contents](#i92d71685303e4745bebf668b98f078d9_7)</u>**

and data centers. We also face global macroeconomic challenges such as inflation, ongoing geopolitical conflicts, uncertainty in the financial markets, volatility in exchange rates, and low or negative growth in certain regions.

Global economic and political conditions and uncertainties, as well as global trade tensions and memory supply constraints, have caused and may continue to cause volatility in demand for our products as well as cost of materials and logistics, and as a result may impact our results of operations. We are continuing to evaluate and implement mitigating actions, including evaluating our pricing strategy across the portfolio and new product pipeline, taking measures to manage our expenses and contain costs, leveraging our supply chain flexibility, inventory management and engineering optimization.

For additional information, see Part II, Item 1A "Risk Factors."

***Seasonality***

Historically, we have typically experienced the highest levels of revenue in the first fiscal quarter of the year coinciding with the holiday shopping season and our promotional activities.

***Key Metrics***

We use the following key metrics, including measures presented in our condensed consolidated financial statements, to evaluate our business, measure our performance, identify trends affecting our business and assist us in making operational and strategic decisions. Our key metrics are total revenue, products sold, Adjusted EBITDA, and Adjusted EBITDA margin. The most directly comparable financial measure calculated under U.S. GAAP for Adjusted EBITDA is net income (loss). The most directly comparable financial measure calculated under U.S. GAAP for Adjusted EBITDA margin is net income (loss) margin.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
| | **March 28,<br>2026** | **March 29,<br>2025** | **March 28,<br>2026** | **March 29,<br>2025** |
| **(In thousands, except percentages)** | | | | |
| Total revenue | $281526 | $259756 | $827189 | $810613 |
| Products sold | 788 | 768 | 2581 | 2618 |
| Net income (loss)  | $(28886) | $(70144) | 64912 | (19907) |
| Net income (loss) margin<sup>(1)</sup> | (10.3)% | (27.0)% | 7.8% | (2.5)% |
| Adjusted EBITDA<sup>(2)</sup> | $1717 | $(826) | 133856 | 90347 |
| Adjusted EBITDA margin<sup>(2)</sup> | 0.6% | (0.3)% | 16.2% | 11.1% |

---

<sup>(1)</sup> Net income (loss) margin is calculated by dividing net income (loss) by revenue.

<sup>(2)</sup> For additional information regarding Adjusted EBITDA and Adjusted EBITDA margin (which are non-GAAP financial measures), including reconciliations of net income to Adjusted EBITDA, see the section titled "Non-GAAP Financial Measures" below.

***Products Sold***

Products sold represents the number of products that are sold during a period, net of returns, and includes units sold from the Sonos speakers and Sonos system products categories, as well as architectural speakers sold through our partnerships from our Partner products and other revenue category. Growth rates between products sold and revenue are not perfectly correlated because our revenue is affected by other variables, such as the mix of products sold during the period, promotional discount activity, the price at which we sell our products, the introduction of new products that may have higher or lower than average selling prices, the impact of foreign exchange rate fluctuations, as well as the impact of recognition of previously deferred revenue.

***Non-GAAP Financial Measures***

To supplement our condensed consolidated financial statements presented in accordance with U.S. GAAP, we use Adjusted EBITDA, Adjusted EBITDA margin, and constant currency which are non-GAAP financial measures. We use these non-GAAP financial measures to evaluate our operating performance and trends and make planning decisions. We believe that these non-GAAP financial measures help identify underlying trends in our business that could otherwise be masked by the effect of the expenses and other items that we exclude from these non-GAAP financial measures. Accordingly, we believe that these non-GAAP financial measures provide useful information to investors and others in understanding and evaluating our operating results, enhancing the overall understanding of our past

------

**<u>[Table of contents](#i92d71685303e4745bebf668b98f078d9_7)</u>**

performance and future prospects, and allowing for greater transparency with respect to a key financial metric used by our management in its financial and operational decision-making.

We define Adjusted EBITDA as net income (loss) adjusted to exclude the impact of depreciation and amortization, stock-based compensation expense, interest income, interest expense, other income (expense), income taxes, legal and transaction related costs, restructuring and other costs, and other items that we do not consider representative of underlying operating performance. We define Adjusted EBITDA margin as Adjusted EBITDA divided by revenue.

We present percentage sales growth in constant currency to show performance unaffected by fluctuations in currency exchange rates. We calculate constant currency growth percentages by translating our current period financial results using the prior period average currency exchange rates and comparing these amounts to our prior period reported results.

These non-GAAP financial measures are not based on standardized methodology prescribed by U.S. GAAP and are not necessarily comparable to similarly titled measures presented by other companies. Furthermore, other companies may not publish these or similar metrics. These metrics may also have certain limitations as they do not include the impact of certain expenses that are reflected in our condensed consolidated statements of operations and comprehensive income, including stock-based compensation, which has been and will continue to be, a significant recurring expense for our business and an important part of our compensation strategy. Because of these limitations, these non-GAAP financial measures should be considered along with other operating and financial performance measures presented in accordance with U.S. GAAP.

The following table presents a reconciliation of net income (loss) to Adjusted EBITDA:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
|  | **March 28,<br>2026** | **March 29,<br>2025** | **March 28,<br>2026** | **March 29,<br>2025** |
| **(In thousands, except percentages)** | | | | |
| Net income (loss)  | $(28886) | $(70144) | $64912 | $(19907) |
| Add (deduct): |  |  |  |  |
| Depreciation and amortization | 11841 | 15167 | 25862 | 32778 |
| Stock-based compensation expense | 14864 | 20102 | 30056 | 45436 |
| Interest income | (1911) | (1973) | (3260) | (3834) |
| Interest expense | 104 | 109 | 220 | 219 |
| Other (income) expense, net | 1361 | (193) | 941 | 5836 |
| Provision for (benefit from) income taxes | (2243) | 10977 | 6027 | 4555 |
| Legal and transaction related costs<sup>(1)</sup> | 3523 | 1429 | 6034 | 1624 |
| Restructuring and other charges<sup>(2)(3)</sup> | 3064 | 23700 | 3064 | 23640 |
| Adjusted EBITDA | $1717 | $(826) | $133856 | $90347 |
| Revenue | $281526 | $259756 | $827189 | $810613 |
| Net income (loss) margin | (10.3)% | (27.0)% | 7.8% | (2.5)% |
| Adjusted EBITDA margin | 0.6% | (0.3)% | 16.2% | 11.1% |

---

<sup>(1)</sup> Legal and transaction-related costs consist of expenses related to our intellectual property ("IP") litigation against Alphabet and Google, which we do not consider representative of our underlying operating performance.

<sup>(2)</sup> Restructuring and other charges for the three and six months ended March 28, 2026, include costs associated with non-recurring organizational changes driven by new leadership, charges related to the partial abandonment of office space in support of operational efficiencies, and costs associated with exiting a partnership with one of our contract manufacturers to consolidate and improve supply chain efficiency.

<sup>(3)</sup> Restructuring and other charges for the three and six months ended March 29, 2025 primarily reflect costs associated with our cost transformation initiative including the 2025 restructuring plan and rationalization of our product roadmap, as well as non-recurring CEO transition costs related to modifications to equity awards.

------

**<u>[Table of contents](#i92d71685303e4745bebf668b98f078d9_7)</u>**

**Results of Operations**

**Comparison of the three and six months ended March 28, 2026 and March 29, 2025**

***Revenue by Product***

*Comparison of the three and six months ended March 28, 2026 and March 29, 2025* 

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Change** | **Six Months Ended** | **Six Months Ended** | **Change** |
| | **March 28,<br>2026** | **March 29,<br>2025** | $**%** | **March 28,<br>2026** | **March 29,<br>2025** | $**%** |
| **(In thousands)** | | | | | | |
| Sonos speakers | $210018 | $194519 | 8.0% | $669258 | $661661 | 1.1% |
| &nbsp;&nbsp;*% of total revenue* | *74.6 %* | *74.9 %* |  | *80.9 %* | *81.6 %* |  |
| Sonos system products | 52411 | 50540 | 3.7 | 117469 | 110814 | 6.0 |
| &nbsp;&nbsp;*% of total revenue* | *18.6 %* | *19.5 %* |  | *14.2 %* | *13.7 %* |  |
| Partner products and other revenue | 19097 | 14697 | 29.9 | 40462 | 38138 | 6.1 |
| &nbsp;&nbsp;*% of total revenue* | *6.8 %* | *5.7 %* |  | *4.9 %* | *4.7 %* |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total revenue | $281526 | $259756 | 8.4% | $827189 | $810613 | 2.0% |
| **Volume data (products sold in thousands)** | **Volume data (products sold in thousands)** | **Volume data (products sold in thousands)** | **%** |  |  | **%** |
| Total products sold | 788 | 768 | 2.6% | 2581 | 2618 | (1.4)% |

---

We generate substantially all of our revenue from the sale of Sonos speakers and Sonos system products. We also generate a portion of revenue from Partner products and other revenue sources, such as architectural speakers from our Sonance partnership, accessories such as speaker stands and wall mounts, professional services, licensing, and advertising revenue.

Total revenue increased $21.8 million, or 8.4 %, for the three months ended March 28, 2026 compared to the three months ended March 29, 2025, due to favorability from foreign exchange rates and continued strength in Era 100.

Sonos speakers revenue represented 74.6% of total revenue for the three months ended March 28, 2026 and increased 8.0 % compared to the three months ended March 29, 2025, primarily driven by Era 100 and Beam. Sonos system products represented 18.6% of total revenue for the three months ended March 28, 2026 and increased 3.7% compared to the three months ended March 29, 2025. Partner products and other revenue represented 6.8% of total revenue for the three months ended March 28, 2026 and increased 29.9% compared to the three months ended March 29, 2025.

The volume of products sold increased 2.6 % for the three months ended March 28, 2026 compared to the three months ended March 29, 2025. Revenue growth exceeded volume growth primarily due to favorable foreign exchange rates, which benefited revenue but did not affect volume, and the impact of pricing actions.

Total revenue increased $16.6 million, or 2.0%, for the six months ended March 28, 2026 compared to the six months ended March 29, 2025, primarily due to favorability from foreign exchange rates and continued strength in Era 100, partially offset by softer demand due to market conditions.

Sonos speakers revenue represented 80.9% of total revenue for the six months ended March 28, 2026 and increased 1.1% compared to the six months ended March 29, 2025, primarily driven by Arc Ultra and Era 100, partially offset by declines in Arc and Sub. Sonos system products represented 14.2% of total revenue for the six months ended March 28, 2026 and increased 6.0% compared to the six months ended March 29, 2025, due to higher sales to our installed solutions channel. Partner products and other revenue represented 4.9% of total revenue for the six months ended March 28, 2026 and increased 6.1% compared to the six months ended March 29, 2025.

The volume of products sold decreased 1.4% for the six months ended March 28, 2026 compared to the six months ended March 29, 2025. Revenue grew while volume declined, primarily due to favorable foreign exchange rates, which benefited revenue but did not impact volume, and the impact of pricing actions.

------

**<u>[Table of contents](#i92d71685303e4745bebf668b98f078d9_7)</u>**

***Revenue by Region***

The following table presents the change in revenue for the three and six months ended March 28, 2026 compared with the three and six months ended March 29, 2025:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>March 28, 2026** | **Three Months Ended<br>March 28, 2026** | **Six Months Ended<br>March 28, 2026** | **Six Months Ended<br>March 28, 2026** |
| | **Change (%)** | **Constant Currency Change (%)**<sup>(1)</sup> | **Change (%)** | **Constant Currency Change (%)**<sup>(1)</sup> |
| Americas | 2.2% | 1.3% | 1.6% | 1.2% |
| EMEA | 20.9% | 9.1% | 2.3% | (5.6)% |
| APAC | 25.3% | 18.1% | 5.3% | 3.4% |
| Total revenue | 8.4% | 4.3% | 2.0% | (0.9)% |

---

<sup>(1)</sup> Constant currency is a financial measure that is not calculated in accordance with U.S. GAAP. For additional information, see the section titled "Non-GAAP Financial Measures" above.

***Cost of Revenue and Gross Profit***

*Comparison of the three and six months ended March 28, 2026 and March 29, 2025*

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Change** | **Six Months Ended** | **Six Months Ended** | **Change** |
|  | **March 28,<br>2026** | **March 29,<br>2025** | $**%** | **March 28,<br>2026** | **March 29,<br>2025** | $**%** |
| **(In thousands, except percentages)** | **(In thousands, except percentages)** | **(In thousands, except percentages)** | **(In thousands, except percentages)** | | | |
| Cost of revenue | $156877 | $146147 | 7.3% | $449080 | $455597 | (1.4)% |
| Gross profit | $124649 | $113609 | 9.7% | $378109 | $355016 | 6.5% |
| Gross margin | 44.3% | 43.7% |  | 45.7% | 43.8% |  |

---

*Cost of Revenue*

Cost of revenue consists of product costs, including costs of our contract manufacturers for production, components, shipping and handling, tariffs, duty costs, warranty replacement costs, packaging, fulfillment costs, manufacturing and tooling equipment depreciation, warehousing costs, hosting costs, and excess and obsolete inventory write-downs. It also includes licensing costs, such as royalties to third parties, and amortization attributable to acquired developed technology. In addition, we attribute certain costs to cost of revenue related to management and facilities, personnel-related expenses, and supply chain logistic costs. Personnel-related expenses consist of salaries, bonuses, benefits, and stock-based compensation expenses.

Cost of revenue increased $10.7 million, or 7.3 %, for the three months ended March 28, 2026 compared to the three months ended March 29, 2025, primarily due to tariff expenses and higher memory costs, partially offset by a decrease in product and material costs.

Cost of revenue decreased $6.5 million, or 1.4%, for the six months ended March 28, 2026 compared to the six months ended March 29, 2025, primarily due to a decrease in product and material costs and fewer inventory-related write-downs, partially offset by increased tariff expenses and higher memory costs.

*Gross Margin* 

Our gross margin fluctuates from period to period based on a number of factors, including the mix of products we sell, the mix of channels through which we sell our products, fluctuations of our product and material cost savings, fluctuations in our product and material and logistics markets, product pricing strategies and promotional activity, the foreign currency in which our products are sold, and tariffs and duty costs implemented by governmental authorities.

Gross margin increased 60 basis points for the three months ended March 28, 2026 compared to the three months ended March 29, 2025, primarily due to foreign exchange rate favorability, the net impact of pricing changes, and a decrease in product and material costs, partially offset by tariff expenses and higher memory costs.

------

**<u>[Table of contents](#i92d71685303e4745bebf668b98f078d9_7)</u>**

Gross margin increased 190 basis points for the six months ended March 28, 2026 compared to the six months ended March 29, 2025, primarily due to a decrease in product and material costs, foreign exchange rate favorability, a decrease in inventory-related write-downs, and the net impact of pricing changes, partially offset by tariff expenses, higher memory costs, and unfavorable product mix.

***Operating Expenses***

*Comparison of the three and six months ended March 28, 2026 and March 29, 2025* 

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Change** | **Six Months Ended** | **Six Months Ended** | **Change** |
| | **March 28, 2026** | **March 29, 2025** | $% | **March 28, 2026** | **March 29, 2025** | $% |
| **(Dollars in thousands)** |  |  |  |  |  |  |
| Research and development | $64134 | $77423 | (17.2)% | $123896 | $158261 | (21.7)% |
| &nbsp;&nbsp;Less restructuring and other charges<sup>(1)(2)</sup> | 857 | 12766 | (93.3) | 857 | 12706 | (93.3) |
| Research and development, net of restructuring and other charges | $63277 | $64657 | (2.1)% | $123039 | $145555 | (15.5)% |
| Sales and marketing | $62376 | $64210 | (2.9)% | $127650 | $150854 | (15.4)% |
| &nbsp;&nbsp;Less restructuring and other charges<sup>(1)(2)</sup> | 1453 | 2792 | (48.0) | 1453 | 2792 | (48.0)% |
| Sales and marketing, net of restructuring and other charges | $60923 | $61418 | (0.8)% | $126197 | $148062 | (14.8)% |
| General and administrative | $29714 | $33200 | (10.5)% | $57723 | $59032 | (2.2)% |
| &nbsp;&nbsp;Less restructuring and other charges<sup>(1)(2)</sup> | 90 | 4207 | (97.9) | 90 | 4207 | (97.9)% |
| General and administrative, net of restructuring and other charges | $29624 | $28993 | 2.2% | $57633 | $54825 | 5.1% |
| Operating expenses | $156224 | $174833 | (10.6)% | $309269 | $368147 | (16.0)% |
| &nbsp;&nbsp;Less restructuring and other charges<sup>(1)(2)</sup> | 2400 | 19765 | (87.9) | 2400 | 19705 | (87.8) |
| Operating expenses, net of restructuring and other charges | $153824 | $155068 | (0.8)% | $306869 | $348442 | (11.9)% |

---

<sup>(1)</sup> Restructuring and other charges for the three and six months ended March 28, 2026, include costs associated with non-recurring organizational changes driven by new leadership, charges related to the partial abandonment of office space in support of operational efficiencies, and costs associated with exiting a partnership with one of our contract manufacturers to consolidate and improve supply chain efficiency.

<sup>(2)</sup> Restructuring and other charges for the three and six months ended March 29, 2025 primarily reflect costs associated with our cost transformation initiative including the 2025 restructuring plan and rationalization of our product roadmap, as well as non-recurring CEO transition costs related to modifications to equity awards.

***Research and Development***

Research and development expenses consist primarily of personnel-related expenses, third-party resource expenses, tooling, test equipment, prototype materials, and related overhead costs. To date, software development costs have been expensed as incurred because the period between achieving technological feasibility and the release of the software has been short and development costs qualifying for capitalization have been insignificant.

------

**<u>[Table of contents](#i92d71685303e4745bebf668b98f078d9_7)</u>**

Research and development expenses, excluding restructuring and other charges, decreased $1.4 million, or 2.1 %, for the three months ended March 28, 2026, compared to the three months ended March 29, 2025. This decrease was primarily driven by lower stock-based compensation related to timing of grants as well as favorable comparison to one time retention grants for key personnel in the prior year.

Research and development expenses, excluding restructuring and other charges, decreased $22.5 million, or 15.5 %, for the six months ended March 28, 2026, compared to the six months ended March 29, 2025. This decrease was primarily driven by lower headcount and our reorganization efforts.

***Sales and Marketing***

Sales and marketing expenses consist primarily of advertising and marketing activity for our products and personnel-related expenses, maintenance and repair expenses for our product displays, as well as depreciation, customer experience expenses, revenue related sales fees from our direct-to-consumer and installer solution sales channels, and related overhead costs.

Sales and marketing expenses, excluding restructuring and other charges, decreased $0.5 million, or 0.8 %, for the three months ended March 28, 2026, compared to the three months ended March 29, 2025. This decrease was primarily driven by ongoing savings efforts associated with cost transformation initiatives, offset by costs associated with announced product launches.

Sales and marketing expenses, excluding restructuring and other charges, decreased $21.9 million, or 14.8 %, for the six months ended March 28, 2026, compared to the six months ended March 29, 2025. This decrease was primarily driven by ongoing savings as a result of our cost transformation journey, lower marketing costs due to the timing of our launch of Arc Ultra in October 2024, and lower personnel-related costs due to lower headcount.

***General and Administrative***

General and administrative expenses consist of administrative personnel-related expenses for our information technology, finance, legal, human resources, and similar personnel, as well as the costs of professional services, information technology, litigation, patents, related overhead, and other administrative expenses.

General and administrative expenses, excluding restructuring and other charges, increased $0.6 million, or 2.2 %, for the three months ended March 28, 2026, compared to the three months ended March 29, 2025. This increase was primarily driven by legal fees mainly related to our IP litigation, offset by lower stock-based compensation mainly due to timing of grants.

General and administrative expenses, excluding restructuring and other charges, increased $2.8 million, or 5.1%, for the six months ended March 28, 2026, compared to the six months ended March 29, 2025. This increase was primarily driven by an increase in legal fees mainly related to our IP litigation, partially offset by lower personnel-related costs due to lower headcount.

***Interest Income, Interest Expense, and Other Income (Expense), Net***

*Comparison of the three and six months ended March 28, 2026 and March 29, 2025*

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Change** | **Six Months Ended** | **Six Months Ended** | **Change** |
| | **March 28,<br>2026** | **March 29,<br>2025** | $**%** | **March 28,<br>2026** | **March 29,<br>2025** | $**%** |
| **(In thousands, except percentages)** | **(In thousands, except percentages)** | **(In thousands, except percentages)** | **(In thousands, except percentages)** | | | |
| &nbsp;&nbsp;&nbsp;Interest income | $1911 | $1973 | (3.1)% | $3260 | $3834 | (15.0)% |
| &nbsp;&nbsp;&nbsp;Interest expense | (104) | (109) | (4.6) | (220) | (219) | 0.5 |
| &nbsp;&nbsp;&nbsp;Other income (expense), net | (1361) | 193 | \* | (941) | (5836) | (83.9) |
| Total other income (expense), net | $446 | $2057 | (78.3)% | $2099 | $(2221) | \* |
| \* Not meaningful |  |  |  |  |  |  |

---

Interest income consists primarily of interest income earned on our cash, cash equivalents, and marketable securities balances. Interest expense consists primarily of interest expense associated with our debt financing arrangements and amortization of debt issuance costs. Other income (expense), net consists primarily of our foreign currency exchange gains and losses relating to transactions and remeasurement of asset and liability balances denominated in currencies other than the U.S. dollar. We expect our foreign currency gains and losses to continue to fluctuate in the future due to changes in foreign currency exchange rates.

------

**<u>[Table of contents](#i92d71685303e4745bebf668b98f078d9_7)</u>**

Interest income and interest expense for the three months ended March 28, 2026 compared to the three months ended March 29, 2025, remained relatively consistent. Other income (expense), net for the three months ended March 28, 2026 compared to the three months ended March 29, 2025, increased from other income of $0.2 million for the three months ended March 29, 2025 to other expense of $1.4 million for the three months ended March 28, 2026 due to foreign currency exchange fluctuations.

Interest income for the six months ended March 28, 2026 compared to the six months ended March 29, 2025, decreased due to higher international cash balances with lower yields. Interest expense for the six months ended March 28, 2026 compared to the six months ended March 29, 2025, remained relatively consistent. Other income (expense), net for the six months ended March 28, 2026 compared to the six months ended March 29, 2025, decreased due to foreign currency exchange fluctuations.

***Provision for (Benefit from) Income Taxes***

*Comparison of the three and six months ended March 28, 2026 and March 29, 2025*

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Change** | **Six Months Ended** | **Six Months Ended** | **Change** |
| | **March 28,<br>2026** | **March 29,<br>2025** | $**%** | **March 28,<br>2026** | **March 29,<br>2025** | $**%** |
| **(In thousands, except percentages)** | **(In thousands, except percentages)** | **(In thousands, except percentages)** | **(In thousands, except percentages)** | | | |
| Provision for (benefit from) income taxes | $(2243) | $10977 | (120.4)% | $6027 | $4555 | 32.3% |

---

We are subject to income taxes in the United States and foreign jurisdictions in which we operate. Foreign jurisdictions have statutory tax rates different from those in the United States. Accordingly, our effective tax rate will vary depending on jurisdictional mix of earnings, and changes in tax laws. In addition, certain U.S. tax regulations subject the earnings of our non-U.S. subsidiaries to current taxation in the United States. Our effective tax rate will be impacted by our ability to claim deductions and foreign tax credits to offset the taxation of foreign earnings in the United States. On July 4, 2025, H.R. 1, commonly referred to as the One Big Beautiful Bill Act ("OBBBA"), was enacted. The legislation includes provisions such as accelerated cost recovery of qualified property, immediate expensing of U.S.-based research and development costs, and changes to the U.S. international taxation regime.

We recognized an income tax benefit of $2.2 million and an income tax provision of $11.0 million for the three months ended March 28, 2026 and March 29, 2025, respectively. For the three months ended March 28, 2026, the repeal of the requirement to capitalize research and experimental expenditures under the OBBBA resulted in a reduction in the Company's U.S. current tax expense with no impact to deferred tax expense as a result of the full valuation allowance maintained against the Company's net U.S. deferred tax assets. The tax provision for the three months ended March 29, 2025 primarily resulted from the application of a negative annual effective tax rate to year-to-date U.S. pre-tax loss for the quarter, which was driven in part by the capitalization of research and experimental expenditures under Section 174 and the valuation allowance maintained against U.S. deferred tax assets. We recognized tax provisions of $6.0 million and $4.6 million for the six months ended March 28, 2026 and March 29, 2025, respectively. This increase was driven by a change in the prescribed U.S. GAAP method to calculate the interim income tax benefit for the period ending March 28, 2026 versus the method used to calculate the income tax provision for the period ending March 29, 2025.

**Liquidity and Capital Resources** 

Our operations are financed primarily through cash flows from operating activities. As of March 28, 2026, our principal sources of liquidity consisted of cash flows from operating activities, cash and cash equivalents of $200.2 million, including $111.2 million held by our foreign subsidiaries, marketable securities of $48.9 million, proceeds from the exercise of stock options, and borrowing capacity under the credit facility under our Revolving Credit Agreement. In accordance with our policy, the undistributed earnings of our non-U.S. subsidiaries remain indefinitely reinvested outside of the United States as of March 28, 2026, as they are intended to fund needs outside of the United States. In the event funds from foreign operations are repatriated to the United States, we may incur income or withholding taxes associated with such distributions. In addition, certain of our non-U.S. subsidiaries have the ability to repatriate funds to the United States in a tax-free manner.

As of March 28, 2026, our open purchase orders to contract manufacturers for finished goods were approximately $92 million, the majority of which are expected to be paid over the next six months. As of March 28, 2026, our expected commitments to suppliers for components were in the range of $198 million to $222 million, the majority of which is expected to be paid and/or utilized by our contract manufacturers in building finished goods within the next two years. The expected commitments are subject to change as a result of fluctuations in the demand forecast, as well as ongoing negotiations with contract manufacturers and suppliers. These commitments are related to components that can be specific to Sonos products and comprised 1) indirect obligations to third-party manufacturers and suppliers, 2) the inventory owned by contract manufacturers procured to manufacture Sonos products, and 3) purchase commitments made by contract manufacturers to their upstream suppliers.

------

**<u>[Table of contents](#i92d71685303e4745bebf668b98f078d9_7)</u>**

We believe our existing cash and cash equivalent balances, cash flows from operations and committed credit lines will be sufficient to meet our long-term working capital and capital expenditure needs for at least the next 12 months. We hold our cash with a diverse group of major financial institutions and have processes and safeguards in place to manage our cash balances and mitigate the risk of loss. In October 2021, we entered into the Revolving Credit Agreement, which was amended in October 2025 to provide for aggregate commitments of up to $80.0 million with a maturity date in October 2030. Our future capital requirements may vary materially from those currently planned and will depend on many factors, including our rate of revenue growth, the timing and extent of spending on research and development efforts and other business initiatives, our planned sales and marketing activities, the timing of new product introductions, our potential merger and acquisition activity, market acceptance of our products, and overall economic conditions. To the extent that current and anticipated sources of liquidity are insufficient to fund our future business activities and requirements, we may be required to seek additional equity or debt financing. The sale of additional equity would result in increased dilution to our stockholders. If we were to incur additional debt financing, it would result in increased debt service obligations and the instruments governing such debt could require additional operating and financing covenants that would restrict our operations.

***Debt Obligations***

On October 13, 2021, we entered into the Revolving Credit Agreement which was amended in October 2025 with JPMorgan Chase Bank, N.A., KeyBank National Association and Goldman Sachs Bank USA. Amendment No. 2 to the Revolving Credit Agreement provides for (i) a five-year senior secured revolving credit facility in the amount of up to $80.0 million and (ii) an uncommitted incremental facility subject to certain conditions. Proceeds are to be used for working capital and general corporate purposes. The facility may be drawn as an Alternative Base Rate Loan (at 1.00% plus an applicable margin) or Term Benchmark Loan (SOFR plus an applicable margin). We must also pay (i) an unused commitment fee ranging from 0.200% to 0.275% per annum of the average daily unused portion of the aggregate revolving credit commitment under the agreement and (ii) a per annum fee equal to the applicable margin over SOFR multiplied by the aggregate face amount of outstanding letters of credit. As of March 28, 2026, we did not have any outstanding borrowings and had $2.4 million in undrawn letters of credit that reduce the availability under the Revolving Credit Agreement.

Our obligations under the Revolving Credit Agreement are secured by substantially all of our assets. The Revolving Credit Agreement contains customary representations and warranties, customary affirmative and negative covenants, a financial covenant that is tested quarterly and requires us to maintain a certain consolidated leverage ratio, and customary events of default. As of March 28, 2026, we were in compliance with all financial covenants under the Revolving Credit Agreement.

***Cash Flows***

The following table summarizes our cash flows for the periods indicated:

---

| | | |
|:---|:---|:---|
| | **Six Months Ended** | **Six Months Ended** |
| | **March 28,<br>2026** | **March 29,<br>2025** |
| **(In thousands)** | | |
| Net cash provided by (used in): |  |  |
| &nbsp;&nbsp;&nbsp;Operating activities | $97933 | $96507 |
| &nbsp;&nbsp;&nbsp;Investing activities | (6813) | (17162) |
| &nbsp;&nbsp;&nbsp;Financing activities | (66692) | (74194) |
| &nbsp;&nbsp;&nbsp;Effect of exchange rate changes | 1060 | (1725) |
| Net increase in cash and cash equivalents | $25488 | $3426 |

---

*Cash flows from operating activities*

Net cash provided by operating activities of $97.9 million for the six months ended March 28, 2026, consisted of net income of $64.9 million, non-cash adjustments of $62.8 million, and an unfavorable impact of net changes in operating assets and liabilities of $29.8 million. Non-cash adjustments primarily consisted of stock-based compensation expense and depreciation and amortization. The net decrease in cash from the change in operating assets and liabilities was primarily due to a decrease in accounts payable and accrued expenses of $33.3 million driven by payments for inventory purchases, and an increase in accounts receivable of $31.7 million driven by the timing of new product launches. The net decrease in cash from the change in operating assets and liabilities was partially offset by an increase in deferred revenue of $17.0 million driven by product general availability deferrals, and a decrease in inventories of $9.8 million due to seasonality.

------

**<u>[Table of contents](#i92d71685303e4745bebf668b98f078d9_7)</u>**

*Cash flows from investing activities*

Cash used in investing activities of $6.8 million for the six months ended March 28, 2026, primarily consisted of the purchases of marketable securities of $25.2 million and purchases of property and equipment of $10.7 million mainly related to manufacturing-related tooling and test equipment to support the launch of new products, partially offset by cash provided by maturities of marketable securities of $29.1 million.

*Cash flows from financing activities*

Cash used in financing activities of $66.7 million for the six months ended March 28, 2026, primarily consisted of payments for repurchases of common stock of $65.1 million, and payments for repurchases of common stock related to shares withheld for tax in connection with vesting of stock awards of $15.9 million, partially offset by proceeds from the exercise of stock options of $15.1 million.

***Commitments and Contingencies***

See Note 7. Commitments and Contingencies in the notes to condensed consolidated financial statements.

**Critical Accounting Policies and Estimates**

Our unaudited condensed consolidated financial statements are prepared in accordance with U.S. GAAP. The preparation of these unaudited condensed consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses, and related disclosures. We evaluate our estimates and assumptions on an ongoing basis. Our estimates are based on historical experience and various other assumptions that we believe to be reasonable under the circumstances. Actual results could differ materially from those estimates.

Other than items discussed in Note 2 of our condensed consolidated financial statements, there have been no material changes to our critical accounting policies as compared to the critical accounting policies and significant judgments and estimates disclosed in our Annual Report on Form 10-K.

**Item 3.&nbsp;&nbsp;&nbsp;&nbsp; Quantitative and Qualitative Disclosures About Market Risk**

We are exposed to financial market risks, including changes in currency exchange rates and interest rates. For quantitative and qualitative disclosures about market risk, refer to Part II, Item 7A, Quantitative and Qualitative Disclosures About Market Risk, in our Annual Report on Form 10-K. Our exposure to market risk has not changed materially, except as follows:

***Foreign Currency Risk***

Our inventory purchases are primarily denominated in U.S. dollars. Our international sales are primarily denominated in foreign currencies and any movement in the exchange rate between the U.S. dollar and the currencies in which we conduct sales in foreign countries could have an impact on our revenue, principally for sales denominated in the euro and the British pound. A portion of our operating expenses are incurred outside the United States and are denominated in foreign currencies, which are also subject to foreign currency exchange rate fluctuations. In certain countries where we may invoice customers in the local currency our revenues benefit from a weaker dollar and are adversely affected by a stronger dollar. The opposite impact occurs in countries where we record expenses in local currencies. In those cases, our costs and expenses benefit from a stronger dollar and are adversely affected by a weaker dollar.

We have not entered into any material foreign exchange contracts or derivatives to hedge any foreign currency exposures. The volatility of exchange rates depends on many factors that we cannot forecast with reliable accuracy. Our continued international expansion increases our exposure to exchange rate fluctuations and, as a result, such fluctuations could have a significant impact on our future results of operations.

For the three months ended March 28, 2026 and March 29, 2025, we recognized a loss from foreign currency exchange of $1.4 million and gain of $0.2 million, respectively. For the six months ended March 28, 2026 and March 29, 2025, we recognized losses from foreign currency exchange of $0.9 million and $5.8 million, respectively. Based on transactions denominated in currencies other than the U.S. dollar as of March 28, 2026, a hypothetical adverse change of 10% would have resulted in an adverse impact on income (loss) before provision for (benefit from) income taxes of approximately $3.1 million and $12.3 million for the three and six months ended March 28, 2026.

------

**<u>[Table of contents](#i92d71685303e4745bebf668b98f078d9_7)</u>**

**Item 4.&nbsp;&nbsp;&nbsp;&nbsp; Controls and Procedures** 

***Evaluation of Disclosure Controls and Procedures***

Under the supervision and with the participation of our management, including the Chief Executive Officer and Chief Financial Officer, we have evaluated the effectiveness of our disclosure controls and procedures as required under Rule 13a-15(b) under the Securities Exchange Act of 1934, as amended ("Exchange Act") as of March 28, 2026. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that these disclosure controls and procedures were effective at a reasonable assurance level as of the end of the period covered by this Quarterly Report on Form 10-Q.

***Changes in Internal Control***

There were no changes in our internal control over financial reporting in management's evaluation pursuant to Rule 13a-15(f) during the quarter ended March 28, 2026, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

------

**<u>[Table of contents](#i92d71685303e4745bebf668b98f078d9_7)</u>**

**PART II. OTHER INFORMATION**

**Item 1. Legal Proceedings**

From time to time, we may become involved in legal proceedings or be subject to claims arising in the ordinary course of our business. Other than the matters described in Note 7. Commitments and Contingencies of the notes to our condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q, we were not a party to any legal proceedings that in the opinion of our management, if determined adversely to us, would individually or taken together have a material adverse effect on our business, operating results, financial condition, or cash flows. Regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources, and other factors.

**Item 1A. Risk Factors** 

Our operations and financial results are subject to various risks and uncertainties, including the factors discussed in Part I, Item 1A, Risk Factors in our Annual Report on Form 10-K for the year ended September 27, 2025, which could adversely affect our business, reputation, financial condition and operating results, and affect the trading price of our common stock. Except as set forth below, there have been no material changes to the risk factors disclosed in our Annual Report.

***We depend on a limited number of third-party components suppliers and logistics providers, and many of our components have long lead times, and our business and operating results could be adversely affected by shortages, disruptions and related challenges.***

We are dependent on a limited number of suppliers for various key components used in our products, and we may from time to time have sole source suppliers. The cost, quality and availability of these components are essential to the successful production and sale of our products. We are subject to the risk of industry-wide shortages, price fluctuations and long lead times in the supply of these components and other materials. In particular, we have been and expect to continue to be adversely impacted by an increase in the cost of certain memory components the supply of which is currently constrained. If the supply of these components is delayed or constrained, or if one or more of our main suppliers were to go out of business, alternative sources or suppliers may not be available on acceptable terms or at all. In the event that any of our suppliers were to discontinue production of our key product components, developing alternate sources of supply for these components would be time consuming, difficult and costly. In the event we are unable to obtain components in sufficient quantities on a timely basis and on commercially reasonable terms, our ability to sell our products in order to meet market demand would be affected and could materially and adversely affect our brand, image, business prospects and operating results.

In addition, the longer lead time for many of our components presents challenges in our efforts to manage component inventory, as we procure such components based on our then current forecast of demand for our products. In the past, we have had to increase our purchase commitments and investments during industry-wide shortages. In the event that actual demand for our products differs from our forecast, we may end up with excess component inventory, negatively impacting our working capital.

We also use a small number of logistics providers for substantially all our product delivery to both distributors and retailers. If one of these providers were to experience financial difficulties or disruptions in its business, or be subject to closures or other disruptions, our own operations could be adversely affected. Because substantially all of our products are distributed from and into a small number of locations and by a small number of companies, we are susceptible to both isolated and system-wide interruptions caused by events out of our control. Any disruption to the operations of our distribution facilities could delay product delivery, harm our reputation among our customers and adversely affect our operating results and financial condition.

We have limited control over the third-party suppliers and logistics providers on which our business depends. If any of these parties fails to perform its obligations to us, we may be unable to deliver our products to customers in a timely manner. Further, we do not have long-term contracts with all of these parties, and there can be no assurance that we will be able to renew our contracts with them on favorable terms or at all. We may be unable to replace an existing supplier or logistics provider or supplement a provider in the event we experience significantly increased demand. Accordingly, a loss or interruption in the service of any key party could adversely impact our revenue, gross margin and operating results.

**Item 2. Unregistered Sales of Equity Securities and Use of Proceeds**

***Recent Sales of Unregistered Securities***

None.

------

**<u>[Table of contents](#i92d71685303e4745bebf668b98f078d9_7)</u>**

***Issuer Purchases of Equity Securities***

On February 24, 2025, the Board of Directors (the "Board") authorized a common stock repurchase program of up to $150.0 million. The following table presents information with respect to the Company's repurchase of common stock during the three months ended March 28, 2026:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Period** | **Total Number of Shares<br>Purchased** | **Average Price Paid per Share**<sup>(1)</sup> | **Total Number of Shares Purchased <br>as Part of Publicly Announced <br>Plans or Programs** | **Approximate Dollar Value of** <br>**Shares that May Yet Be** <br>**Purchased Under the Plans or** <br>**Programs**<br>**(in thousands)**<sup>(2)</sup> |
| Dec 28 - Jan 24 |  | $— |  | $104648 |
| Jan 25 - Feb 21 | 1406542 | $16.28 | 1406542 | $81753 |
| Feb 22 - Mar 28 | 1120074 | $15.11 | 1120074 | $64834 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | 2526616 |  | 2526616 |  |

---

<sup>(1)</sup> Aggregate purchase price and average price per share exclude commission and excise tax. See Note 8. Stockholders' Equity of the Company's condensed consolidated financial statements for further information.

<sup>(2)</sup> Approximate dollar value of shares that may yet be purchased under the plans or programs does not include the impact of direct costs incurred to acquire shares.

**Item 3. Defaults Upon Senior Securities**

None.

**Item 4. Mine Safety Disclosures**

None.

**Item 5. Other Information** 

***Rule 10b5-1 Trading Plans and Non-Rule 10b5-1 Trading Arrangements***

None.

------

**<u>[Table of contents](#i92d71685303e4745bebf668b98f078d9_7)</u>**

**Item 6. Exhibit Index**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | | **Incorporated by reference** | **Incorporated by reference** | **Incorporated by reference** | **Incorporated by reference** | **Incorporated by reference** |
|<br>**Exhibit**<br>**number** |<br>**Exhibit title** | **Form** | **File no.** | **Exhibit** | **Filing<br>date** | **Filed or<br>furnished<br>herewith** |
| 3.1 | <u>[A](https://www.sec.gov/Archives/edgar/data/1314727/000131472726000050/exhibit31.htm)[mendmen](https://www.sec.gov/Archives/edgar/data/1314727/000131472726000050/exhibit31.htm)[t to Company](https://www.sec.gov/Archives/edgar/data/1314727/000131472726000050/exhibit31.htm)['s Re](https://www.sec.gov/Archives/edgar/data/1314727/000131472726000050/exhibit31.htm)[stated Certifi](https://www.sec.gov/Archives/edgar/data/1314727/000131472726000050/exhibit31.htm)[cat](https://www.sec.gov/Archives/edgar/data/1314727/000131472726000050/exhibit31.htm)[e of Incorporation](https://www.sec.gov/Archives/edgar/data/1314727/000131472726000050/exhibit31.htm)</u> | 8-K | 001-38603 | 3.1 | 3/11/2026 |  |
| 3.2 | <u>[A](https://www.sec.gov/Archives/edgar/data/1314727/000131472726000050/exhibit32.htm)[mendme](https://www.sec.gov/Archives/edgar/data/1314727/000131472726000050/exhibit32.htm)[nt to Company's Restate](https://www.sec.gov/Archives/edgar/data/1314727/000131472726000050/exhibit32.htm)[d Bylaws](https://www.sec.gov/Archives/edgar/data/1314727/000131472726000050/exhibit32.htm)</u> | 8-K | 001-38603 | 3.2 | 3/11/2026 |  |
| 31.1 | <u>[Certification of Chief Executive Officer pursuant to Rules 13a-14(a) and Rule 15d-14(a) of the Exchange Act](ex-311q2fy26.htm)</u> |  |  |  |  | X |
| 31.2 | <u>[Certification of Chief Financial Officer pursuant to Rules 13a-14(a) and Rule 15d-14(a) of the Exchange Act](ex-312q2fy26.htm)</u> |  |  |  |  | X |
| 32.1\* | <u>[Certification of Chief Executive Officer pursuant to Rule 13a-14(b) of the Exchange Act and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002](ex-321q2fy26.htm)</u> |  |  |  |  | X |
| 32.2\* | <u>[Certification of Chief Financial Officer pursuant to Rule 13a-14(b) of the Exchange Act and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002](ex-322q2fy26.htm)</u> |  |  |  |  | X |
| 101 | The following financial statements from the Company's Quarterly Report on Form 10-Q for the quarter ended March 28, 2026, formatted in Inline XBRL: (i) Condensed consolidated balance sheets, (ii) Condensed consolidated statements of operations and comprehensive income (loss), (iv) Condensed consolidated statements of stockholders' equity, (v) Condensed consolidated statements of cash flows and (vi) Notes to condensed consolidated financial statements, tagged as blocks of text and including detailed tags |  |  |  |  | X |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |  |  |  |  | X |

---

\**The certifications furnished in Exhibits 32.1 and 32.2 hereto are deemed to accompany this Form 10-Q and are not deemed "filed" for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, nor shall they be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act.*

*+ Indicates a management contract or compensatory plan or arrangement.*

------

**<u>[Table of contents](#i92d71685303e4745bebf668b98f078d9_7)</u>**

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | |
|:---|:---|:---|
| | | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Sonos, Inc.** |
| &nbsp;&nbsp;Date: May 4, 2026 | By: | /s/ Tom Conrad |
|  |  | Tom Conrad |
|  |  | Chief Executive Officer  |
|  |  | &nbsp;&nbsp;&nbsp;*(Principal Executive Officer)* |
| &nbsp;&nbsp;Date: May 4, 2026 | By: | /s/ Saori Casey |
|  |  | Saori Casey |
|  |  | Chief Financial Officer |
|  |  | *(Principal Financial Officer and Principal Accounting Officer)* |

---

## Exhibit 31.1

**Exhibit 31.1**

**CERTIFICATION OF CHIEF EXECUTIVE OFFICER**

**PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, Tom Conrad, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.I have reviewed this Quarterly Report on Form 10-Q of Sonos, Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| Date: May 4, 2026 | /s/ Tom Conrad |
| | Tom Conrad |
| | Chief Executive Officer<br>(Principal Executive Officer) |

---

## Exhibit 31.2

**Exhibit 31.2**

**CERTIFICATION OF CHIEF FINANCIAL OFFICER**

**PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, Saori Casey, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.I have reviewed this Quarterly Report on Form 10-Q of Sonos, Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| Date: May 4, 2026 | /s/ Saori Casey |
| | Saori Casey |
| | Chief Financial Officer <br>(Principal Financial Officer and Principal Accounting Officer) |

---

## Exhibit 32.1

**Exhibit 32.1**

**CERTIFICATION OF CHIEF EXECUTIVE OFFICER**

**PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

I, Tom Conrad, Chief Executive Officer of Sonos, Inc. (the "Company"), hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge, this Quarterly Report on Form 10-Q of the Company for the fiscal quarter ended March 28, 2026 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in such Quarterly Report on Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | | |
|:---|:---|:---|
| Date: May 4, 2026 | By: | /s/ Tom Conrad |
|  |  | Tom Conrad |
|  |  | Chief Executive Officer<br>(Principal Executive Officer) |

---

## Exhibit 32.2

**Exhibit 32.2**

**CERTIFICATION OF CHIEF FINANCIAL OFFICER**

**PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

I, Saori Casey, Chief Financial Officer of Sonos, Inc. (the "Company"), hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge, this Quarterly Report on Form 10-Q of the Company for the fiscal quarter ended March 28, 2026 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in such Quarterly Report on Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | | |
|:---|:---|:---|
| Date: May 4, 2026 | By: | /s/ Saori Casey |
|  |  | Saori Casey |
|  |  | Chief Financial Officer <br>(Principal Financial Officer and Principal Accounting Officer) |

---

<br>